IPO
Coverage Timeline
newest first- Sep 4, 2026One of Eight IPO Candidates Just Actually Filed→
- Sep 4, 2026Why AI Infrastructure Beat AI Labs to the Public Markets→
- Sep 4, 20262026's IPO Pops Are Fading Into Real Trading Ranges→
- Sep 3, 2026Ten More Companies Filed to Go Public→
- Sep 3, 2026Crusoe Meets IPO Bankers Less Than a Year After $10B→
- Sep 3, 2026Oura Files to Go Public at $16B-Plus$16B+ IPO valuation→
- Sep 3, 2026It Takes $25M to Get Into Anthropic's Cap Table→
- Sep 2, 2026OpenAI and Anthropic Race to List Without Breaking Safety→
- Sep 2, 2026Eight Startups Racing a Closing 2026 IPO Window→
- Sep 1, 2026Twelve Companies Filed to Go Public in Forty-Eight Hours→
- Sep 1, 2026Why This Week's Real IPO Story Is Old Economy, Not AI→
- Sep 1, 2026Unacademy Sells for $206M After a $3.4B Peak$206M all-stock→
- Sep 1, 2026Why I'm Wary of OpenAI's Circular Financing Web→
- Sep 1, 2026SB Energy Files IPO, Warns It's Tied to OpenAI$5-7B target raise→
- Sep 1, 2026Entrata Refiles Its S-1, Betting Software IPOs Are Back$500M target raise→
- Sep 1, 2026KKR-Backed Wella Files for a NYSE Listing as 'WELA'$2.9B FY26 revenue→
- Sep 1, 2026Oura's $16B IPO Bet: Can a Wearable Price Like Software?$16B+ target valuation→
- Aug 31, 2026What SpaceX's Record IPO Means for What's Next→
- Aug 31, 2026Tailored Brands Refiles IPO, Plots 500 New Men's Wearhouse Stores$681.8M quarterly revenue→
- Aug 31, 2026Syntiant's 'Edge AI' IPO Pitch Is Mostly a Microphone Business~$300M target IPO→
- Aug 31, 2026Why Anthropic's IPO Is Shaping Up as AI's Biggest Test~$965B valuation→
- Aug 31, 2026The Fall IPO Pipeline, By the Numbers237 IPOs YTD→
- Aug 31, 2026DeepSeek's Road to a 2027 IPO Looks Nothing Like Anthropic's$7.4B round target→
- Aug 31, 2026Salesforce's $5.1B Anthropic Stake Prices Strategic AI Bets$5.1B stake value→
- Aug 31, 2026Nscale's $51 Billion Number Isn't What It Looks Like$51B contracted→
- Aug 31, 2026Kakao Mobility's Bet on a US Listing~$1B target listing→
- Aug 31, 2026Why I'm Skeptical of the 'IPO Window Is Open' Story→
- Aug 28, 2026Amaero Files to List on Nasdaq as Defense Metals Maker→
- Aug 28, 2026Space Startups Have Raised $20.3B in 2026$20.3B YTD→
- Aug 28, 2026Affirm's GMV Hits $50B as Levchin Flags Gas Prices$14.1B quarterly GMV→
- Aug 28, 2026Marvell Guided to 50% Growth and Fell 6%-6% on the day→
- Aug 28, 2026GTA 6 Preview Breaks Streams, Lifts Take-Two→
- Aug 28, 2026Salesforce's Agentforce ARR Tops $1.5B as Benioff Silences Bears$1.5B Agentforce ARR→
- Aug 28, 2026This Week in S-1s: Eight Filings, Zero Unicorns→
- Aug 28, 2026BlackBerry's Second Life Runs on QNX in Cars and Robots→
- Aug 28, 2026Marvell, Rubrik, SentinelOne Beat -- Stocks Fall Anyway→
- Aug 28, 2026Nvidia Now Carries $366B in Future Commitments$366B in commitments→
- Aug 28, 2026DeepSeek Hunts Outside Capital Before a STAR ListingUp to $71B valuation→
- Aug 28, 20262026 Is Already a Record Year for Tech IPOs235 IPOs YTD→
- Aug 27, 2026Anthropic Pitches a $30 Trillion Market, OpenAI Slips$30T claimed TAM→
All Coverage
IPO
One of Eight IPO Candidates Just Actually Filed
Crunchbase named eight startups as 2026's clearest IPO candidates two days ago; since then, exactly one -- Oura -- has converted to an actual public S-1, while the other seven remain unfiled.
FOLLOW-UP
IPO
Why AI Infrastructure Beat AI Labs to the Public Markets
IPO
Why AI Infrastructure Beat AI Labs to the Public Markets
Crusoe is meeting IPO bankers and Oura just filed while OpenAI and Anthropic sit confidentially filed with no date -- I think that gap is permanent, and it tells you where the real underwriting risk in this cycle sits.
TRACE'S TAKE
IPO
2026's IPO Pops Are Fading Into Real Trading Ranges
IPO
2026's IPO Pops Are Fading Into Real Trading Ranges
Cerebras opened at $350 against a $185 IPO price and has since traded back near its offer price, while SpaceX climbed roughly 19% in a month on an Oppenheimer price-target raise -- proof first-day pops and durable value differ.
DEEP DIVE
IPO
Ten More Companies Filed to Go Public
IPO
Ten More Companies Filed to Go Public
A new wave of SEC registrations hit EDGAR on Sept. 3, led by Oura's blockbuster filing but including a defense-tech company near Nasdaq delisting and a going-concern cybersecurity filer trading under $1 a share.
FOLLOW-UP
IPO
Crusoe Meets IPO Bankers Less Than a Year After $10B
IPO
Crusoe Meets IPO Bankers Less Than a Year After $10B
Crusoe has met with Goldman Sachs, Morgan Stanley, JPMorgan and Bank of America about a near-term IPO, the same week it reportedly closed a $3 billion round at $30 billion -- an unusually fast run from markup to public talks.
DEEP DIVE
IPO
Oura Files to Go Public at $16B-Plus
IPO$16B+ IPO valuation
Oura Files to Go Public at $16B-Plus
Oura filed publicly for a Nasdaq listing under the ticker OURA, disclosing revenue up 74% to $1.21 billion over nine months and 5 million paid members, in an offering that could raise as much as $3 billion.
FOLLOW-UP
IPO
It Takes $25M to Get Into Anthropic's Cap Table
IPO
It Takes $25M to Get Into Anthropic's Cap Table
Secondary-market brokers say it now takes at least $25 million to access Anthropic shares at a roughly $1.4 trillion valuation, versus as little as $500,000 to $1 million for OpenAI, reflecting scarce supply.
DEEP DIVE
IPO
OpenAI and Anthropic Race to List Without Breaking Safety
IPO
OpenAI and Anthropic Race to List Without Breaking Safety
Both labs have confidentially filed with the SEC and both spent the past week publicly disclosing safety failures, setting up the hardest question in their prospectuses: how to price a company whose main risk factor is its own product.
FOLLOW-UP
IPO
Eight Startups Racing a Closing 2026 IPO Window
IPO
Eight Startups Racing a Closing 2026 IPO Window
Crunchbase identified eight startups -- including Anthropic, Oura, Notion, Kraken and SambaNova -- as candidates for a narrowing 2026 IPO window, with SpaceX's record June listing as the template.
DEEP DIVE
IPO
Twelve Companies Filed to Go Public in Forty-Eight Hours
IPO
Twelve Companies Filed to Go Public in Forty-Eight Hours
Between Aug. 31 and Sept. 1, twelve registration statements hit EDGAR spanning AI power infrastructure, beauty, menswear, edge silicon, property software and a SPAC -- one of the densest filing stretches of the year.
FOLLOW-UP
IPO
Why This Week's Real IPO Story Is Old Economy, Not AI
IPO
Why This Week's Real IPO Story Is Old Economy, Not AI
Four S-1s hit this week -- a beauty conglomerate, a profitable proptech, an edge-AI chipmaker whose revenue is mostly microphones, and a menswear retailer -- and none of them are the AI mega-caps everyone's actually watching this fall.
TRACE'S TAKE
IPO
Unacademy Sells for $206M After a $3.4B Peak
IPO$206M all-stock
Unacademy Sells for $206M After a $3.4B Peak
upGrad closed its all-stock purchase of Unacademy on Sept. 1 at about $206 million, roughly 94% below the $3.44 billion valuation SoftBank, Tiger Global and General Atlantic backed in 2021.
DEEP DIVE
IPO
Why I'm Wary of OpenAI's Circular Financing Web
IPO
Why I'm Wary of OpenAI's Circular Financing Web
OpenAI's expanding financial ties to SB Energy -- as tenant, investor and warrant holder -- raise questions about how much of AI infrastructure's 'market price' is actually set by related parties.
TRACE'S TAKE
IPO
SB Energy Files IPO, Warns It's Tied to OpenAI
IPO$5-7B target raise
SB Energy Files IPO, Warns It's Tied to OpenAI
SoftBank-backed SB Energy filed for a US IPO warning investors it is substantially dependent on OpenAI, which is both its largest tenant and an equity holder.
DEEP DIVE
IPO
Entrata Refiles Its S-1, Betting Software IPOs Are Back
IPO$500M target raise
Entrata Refiles Its S-1, Betting Software IPOs Are Back
Entrata amended its S-1 pitching a rare combination for a 2026 IPO candidate: $575M ARR growing 23%, GAAP operating profitability, and 117% net retention -- a direct test of investor appetite for software this year.
DEEP DIVE
IPO
KKR-Backed Wella Files for a NYSE Listing as 'WELA'
IPO$2.9B FY26 revenue
KKR-Backed Wella Files for a NYSE Listing as 'WELA'
Wella, the KKR-backed owner of Clairol and OPI, filed for a US IPO on the NYSE with $2.9 billion in fiscal 2026 revenue, six years after being carved out of Coty in a deal that valued the business at $4.3 billion.
DEEP DIVE
IPO
Oura's $16B IPO Bet: Can a Wearable Price Like Software?
IPO$16B+ target valuation
Oura's $16B IPO Bet: Can a Wearable Price Like Software?
Oura is targeting a US IPO that could raise up to $3 billion at a valuation above $16 billion -- a 45% jump from last September's mark, riding revenue that's gone from $500M to a projected $2B in two years.
DEEP DIVE
IPO
What SpaceX's Record IPO Means for What's Next
IPO
What SpaceX's Record IPO Means for What's Next
SpaceX's June IPO priced at a $1.77 trillion valuation, the largest in history -- and the fall pipeline behind it, from Anthropic to DeepSeek to Kakao Mobility, is the real test of whether that was a ceiling or a floor.
BY THE NUMBERS
IPO
Tailored Brands Refiles IPO, Plots 500 New Men's Wearhouse Stores
IPO$681.8M quarterly revenue
Tailored Brands Refiles IPO, Plots 500 New Men's Wearhouse Stores
Tailored Brands, owner of Men's Wearhouse and Jos. A. Bank, amended its IPO filing with $681.8 million in quarterly revenue and plans to fund a 500-store expansion -- a bet that brick-and-mortar menswear retail still has room to grow.
DEEP DIVE
IPO
Syntiant's 'Edge AI' IPO Pitch Is Mostly a Microphone Business
IPO~$300M target IPO
Syntiant's 'Edge AI' IPO Pitch Is Mostly a Microphone Business
Syntiant is pitching investors on a roughly $300M edge-AI chip IPO, but about 95% of its most recent quarterly revenue actually comes from a sensor business -- mostly microphones -- it acquired in 2024, not from AI chip sales.
DEEP DIVE
IPO
Why Anthropic's IPO Is Shaping Up as AI's Biggest Test
IPO~$965B valuation
Why Anthropic's IPO Is Shaping Up as AI's Biggest Test
Anthropic's revenue run-rate hit $65 billion in July and its S-1 is filed ahead of a post-Labor-Day reveal -- here's what has to hold up for its reported ~$965 billion valuation to survive public markets.
DEEP DIVE
IPO
The Fall IPO Pipeline, By the Numbers
IPO237 IPOs YTD
The Fall IPO Pipeline, By the Numbers
237 IPOs have priced in the US so far in 2026, up 3% from this point last year -- but August was a pause, and the real test is whether Anthropic, DeepSeek, Nscale and Kakao Mobility actually price in the weeks ahead.
BY THE NUMBERS
IPO
DeepSeek's Road to a 2027 IPO Looks Nothing Like Anthropic's
IPO$7.4B round target
DeepSeek's Road to a 2027 IPO Looks Nothing Like Anthropic's
DeepSeek is trying to close a second $7.4 billion round at a $74 billion valuation ahead of a targeted 2027 Shanghai listing -- a governance structure with almost nothing in common with Anthropic's path.
DEEP DIVE
IPO
Salesforce's $5.1B Anthropic Stake Prices Strategic AI Bets
IPO$5.1B stake value
Salesforce's $5.1B Anthropic Stake Prices Strategic AI Bets
Salesforce's stock jumped as much as 23% on its own earnings this week, and its Anthropic stake gained $2.6 billion in the process -- the clearest market-priced signal yet of what a strategic bet on a frontier lab is actually worth.
DEEP DIVE
IPO
Nscale's $51 Billion Number Isn't What It Looks Like
IPO$51B contracted
Nscale's $51 Billion Number Isn't What It Looks Like
Nscale is telling IPO investors it has $51 billion in contracted revenue -- but that figure counts multi-year compute deals the moment they're signed, and the company's actual annualized run-rate is closer to $400-500 million.
DEEP DIVE
IPO
Kakao Mobility's Bet on a US Listing
IPO~$1B target listing
Kakao Mobility's Bet on a US Listing
Kakao Mobility filed confidential US IPO paperwork targeting roughly a $1 billion listing, with TPG seeking an exit -- a rare instance of a Korean tech company choosing Wall Street over its home exchange.
DEEP DIVE
IPO
Why I'm Skeptical of the 'IPO Window Is Open' Story
IPO
Why I'm Skeptical of the 'IPO Window Is Open' Story
Everyone's calling this the best IPO market in years, and the aggregate numbers back that up -- but Monday's tape and Lyntris's soft debut are the two data points the bulls keep leaving out.
TRACE'S TAKE
IPO
Amaero Files to List on Nasdaq as Defense Metals Maker
IPO
Amaero Files to List on Nasdaq as Defense Metals Maker
Amaero Inc., which makes high-purity metal powders for hypersonic weapons, satellite propulsion and aerospace 3D printing, publicly filed its S-1 to list on Nasdaq under the ticker AMRO, six weeks after confidentially submitting the draft registration.
DEEP DIVE
IPO
Space Startups Have Raised $20.3B in 2026
IPO$20.3B YTD
Space Startups Have Raised $20.3B in 2026
Global venture funding to space and satellite startups reached $20.3 billion through August 2026, already the highest annual total on record, with U.S. companies taking roughly $12.7 billion of it.
BY THE NUMBERS
IPO
Affirm's GMV Hits $50B as Levchin Flags Gas Prices
IPO$14.1B quarterly GMV
Affirm's GMV Hits $50B as Levchin Flags Gas Prices
Affirm reported fiscal fourth-quarter GMV of $14.1 billion, up 36%, and $50.2 billion for the year, while CEO Max Levchin warned that high gasoline prices are squeezing U.S. shoppers.
DEEP DIVE
IPO
Marvell Guided to 50% Growth and Fell 6%
IPO-6% on the day
Marvell Guided to 50% Growth and Fell 6%
Marvell posted record revenue of $2.74 billion, up 37%, raised its fiscal 2028 target to about $18 billion, and the stock still dropped 6% -- a lesson in what AI multiples now require.
TRACE'S TAKE
IPO
GTA 6 Preview Breaks Streams, Lifts Take-Two
IPO
GTA 6 Preview Breaks Streams, Lifts Take-Two
Rockstar's 27-minute Grand Theft Auto VI preview premiered exclusively on Netflix and overwhelmed streaming platforms, pushing Take-Two shares higher as Morgan Stanley and JPMorgan reiterated bullish calls.
DEEP DIVE
IPO
Salesforce's Agentforce ARR Tops $1.5B as Benioff Silences Bears
IPO$1.5B Agentforce ARR
Salesforce's Agentforce ARR Tops $1.5B as Benioff Silences Bears
Salesforce posted $11.35 billion in quarterly revenue and said Agentforce annual recurring revenue passed $1.5 billion, up more than 240%, undercutting the argument that AI agents would erode seat-based software.
DEEP DIVE
IPO
This Week in S-1s: Eight Filings, Zero Unicorns
IPO
This Week in S-1s: Eight Filings, Zero Unicorns
Eight S-1 and S-1/A filings hit EDGAR between Aug. 26 and Aug. 27 -- a blank-check shell, a Reg A graduate, a convenience-store operator and a biotech among them, with no venture-scale technology company in the group.
BY THE NUMBERS
IPO
BlackBerry's Second Life Runs on QNX in Cars and Robots
IPO
BlackBerry's Second Life Runs on QNX in Cars and Robots
A decade after exiting handsets, BlackBerry is pitching its QNX embedded operating system as the safety-certified software layer for vehicles and, increasingly, robots.
DEEP DIVE
IPO
Marvell, Rubrik, SentinelOne Beat -- Stocks Fall Anyway
IPO
Marvell, Rubrik, SentinelOne Beat -- Stocks Fall Anyway
Marvell, Rubrik and SentinelOne all beat quarterly estimates and raised or met guidance, yet all three stocks fell, a signal that investors are pricing AI-adjacent names for perfection rather than just growth.
TRACE'S TAKE
IPO
Nvidia Now Carries $366B in Future Commitments
IPO$366B in commitments
Nvidia Now Carries $366B in Future Commitments
Nvidia disclosed $366 billion of future commitments -- including $279 billion of supply and capacity, up from $119 billion -- while quarterly free cash flow fell from $48.5 billion to $21.3 billion.
DEEP DIVE
IPO
DeepSeek Hunts Outside Capital Before a STAR Listing
IPOUp to $71B valuation
DeepSeek Hunts Outside Capital Before a STAR Listing
DeepSeek is seeking new outside capital at a valuation reported as high as $71 billion, unable to lean on founder Liang Wenfeng's hedge fund, as it aims for a Shanghai STAR Market listing as early as Q2 2027.
DEEP DIVE
IPO
2026 Is Already a Record Year for Tech IPOs
IPO235 IPOs YTD
2026 Is Already a Record Year for Tech IPOs
US tech IPOs have already topped 235 listings in 2026 with Q2 setting an all-time quarterly record, and OpenAI and Anthropic are both racing toward listings that could each rival or exceed SpaceX's record-setting June debut.
DEEP DIVE
IPO
Anthropic Pitches a $30 Trillion Market, OpenAI Slips
IPO$30T claimed TAM
Anthropic Pitches a $30 Trillion Market, OpenAI Slips
Anthropic is preparing to tell IPO investors its addressable market tops $30 trillion, exceeding SpaceX's record TAM claim, while OpenAI's CFO has told employees a public listing is more likely in 2027 than 2026.
DEEP DIVE
IPO
Rivian Loses Its CFO to GE Vernova
IPO
Rivian Loses Its CFO to GE Vernova
Claire McDonough is leaving Rivian on Oct. 30 after nearly six years as CFO to take the same role at GE Vernova, with VP of finance Derek Mulvey stepping in on an interim basis.
DEEP DIVE
IPO
CrowdStrike, Okta Post Best Days Ever on AI Demand
IPO
CrowdStrike, Okta Post Best Days Ever on AI Demand
CrowdStrike and Okta both surged on quarterly earnings beats and raised guidance, with executives citing accelerating AI-driven security threats as a demand driver for both companies' platforms.
DEEP DIVE
IPO
IREN Raises AI Cloud Revenue Target to $4B
IPO$4B+ AI cloud target
IREN Raises AI Cloud Revenue Target to $4B
IREN raised its 2026 AI cloud revenue target above $4 billion after signing $2.8 billion in new multi-year contracts, even as it posted a quarterly loss wider than analysts expected.
DEEP DIVE
IPO
CrowdStrike Rallies as Its CEO Sells the AI Gap
IPO
CrowdStrike Rallies as Its CEO Sells the AI Gap
CrowdStrike CEO George Kurtz argues AI is exposing security gaps legacy tools cannot handle, a thesis carrying the stock through a comeback rally that Jim Cramer says still has room to run.
DEEP DIVE
IPO
CoreWeave Surges 20% on a $104B Revenue Backlog
IPO$104B revenue backlog
CoreWeave Surges 20% on a $104B Revenue Backlog
CoreWeave's stock jumped roughly 20% after second-quarter revenue nearly doubled from a year earlier to $2.58 billion and the company disclosed a $104 billion revenue backlog anchored by AI cloud demand.
DEEP DIVE
IPO
Why This Week's IPO Pipeline Is All Micro-Caps
IPO12 S-1 filings
Why This Week's IPO Pipeline Is All Micro-Caps
This week's SEC filing wave is dominated by small, often distressed public companies doing dilutive registrations rather than marquee venture-backed IPOs -- a reminder the S-1 pipeline and real IPO news are different datasets.
BY THE NUMBERS
IPO
Reliance Global Group Files Fresh S-1 for Dilution
IPOS-1 registration
Reliance Global Group Files Fresh S-1 for Dilution
Insurance-tech roll-up Reliance Global Group filed another S-1 registration, its latest in a string of dilutive capital raises this year that has repeatedly pressured the already-small-cap stock.
DEEP DIVE
IPO
Reliance Global Group Files S-1 for 16.1M White Lion Resale Shares
IPO16.1M resale shares
Reliance Global Group Files S-1 for 16.1M White Lion Resale Shares
InsurTech roll-up Reliance Global Group (EZRA) filed an S-1 registering 16.1 million resale shares tied to its expanded $50 million White Lion equity line, as commission income fell to $2.1 million in Q2 -- down a third year over year.
DEEP DIVE
IPO
Ocean Power Tech Files S-1 Amid Delisting Risk
IPOS-1 registration
Ocean Power Tech Files S-1 Amid Delisting Risk
Ocean Power Technologies filed a new S-1 registration days after NYSE American flagged it for late-filing its annual report, a compliance scramble it resolved by filing its 10-K just before this week's capital-raise registration.
DEEP DIVE
IPO
Big Tech Is Hiding $3 Trillion of AI Bills in Footnotes
IPO$3T off balance sheet
Big Tech Is Hiding $3 Trillion of AI Bills in Footnotes
Nine large tech companies carry roughly $3 trillion of off-balance-sheet commitments tied to AI, about five times their combined reported capex and triple what they owe on leases and long-term borrowings.
DEEP DIVE
IPO
This Week's SEC Filing Wave: 10+ New S-1s Land
IPO
This Week's SEC Filing Wave: 10+ New S-1s Land
More than a dozen companies filed S-1 registration statements with the SEC in a single week, spanning defense-tech, biotech, gaming and micro-cap issuers -- a snapshot of how much routine filing volume runs through EDGAR weekly.
BY THE NUMBERS
IPO
Starfighters Space Amends S-1 After PIPE Closing
IPO
Starfighters Space Amends S-1 After PIPE Closing
Starfighters Space, which flies a fleet of seven Mach 2+ F-104 fighter jets from Cape Canaveral toward a suborbital launch license, filed an S-1/A registering resale shares from a May 2026 PIPE placed by Cantor Fitzgerald.
DEEP DIVE
IPO
Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness
IPO
Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness
Dare Bioscience registered resale shares tied to an August warrant placement, while RZ Wellness amended its S-1 to sell 5.5 million shares at 3 cents apiece for a $165,000 OTCQB offering -- among the smallest public raises on record.
BY THE NUMBERS
IPO
Sadot Group Warns of 'Going Concern' in S-1/A
IPO$200M financing package
Sadot Group Warns of 'Going Concern' in S-1/A
Sadot Group filed an amended S-1 registering 4.25 million resale shares tied to a $200 million financing package, disclosing a going-concern warning, a $13.6 million working-capital deficit and zero commodity revenue for the quarter.
DEEP DIVE
IPO
Capstone 72 Files to List Its Home-Flipping REIT
IPO
Capstone 72 Files to List Its Home-Flipping REIT
Capstone 72, a Cleveland-founded single-family home renovation and resale platform, amended its S-11 to price shares at $4 and list on Nasdaq under CAPI, targeting expansion into Los Angeles, the Bay Area and Chicago in 2026.
DEEP DIVE
IPO
Southern Cross Acquisition II Prices $75M SPAC IPO
IPO$75M SPAC IPO
Southern Cross Acquisition II Prices $75M SPAC IPO
Southern Cross Acquisition II priced a downsized $75 million SPAC IPO on Nasdaq, cutting its offering by 25% from an original 10 million units to 7.5 million ahead of trading under ticker SCATU.
DEEP DIVE
IPO
Failed Crypto SPAC Rebrands as Velos, Extends Runway
IPO
Failed Crypto SPAC Rebrands as Velos, Extends Runway
M3-Brigade Acquisition V Corp renamed itself Velos Acquisition I Corp after its business combination with digital-asset firm ReserveOne collapsed, with shareholders extending the SPAC's deadline to August 2027.
DEEP DIVE
IPO
Two More S-1s Land: Enhanced Group, Serina Therapeutics
IPO
Two More S-1s Land: Enhanced Group, Serina Therapeutics
Enhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.
BY THE NUMBERS
IPO
Shein Prices Hong Kong IPO at $27B, Down 70% From Peak
IPO
Shein Prices Hong Kong IPO at $27B, Down 70% From Peak
Shein launched its long-delayed Hong Kong IPO at a valuation of roughly $27 billion, a 70% drop from the $98.2 billion private-market mark it carried in 2022, as revenue growth has nearly stalled.
FOLLOW-UP
IPO
Ten SPAC and S-1 Filings Hit the Tape in 48 Hours
IPO
Ten SPAC and S-1 Filings Hit the Tape in 48 Hours
At least ten S-1 and SPAC registration filings landed with the SEC over August 24-25, 2026, spanning energy, biotech, fuel delivery and five separate blank-check companies.
BY THE NUMBERS
IPO
Ocean Power Technologies Files S-1 for New Offering
IPO
Ocean Power Technologies Files S-1 for New Offering
Ocean Power Technologies, a publicly traded wave-energy and marine-robotics company built around its PowerBuoy platform, filed a new S-1 registration with the SEC on August 25, 2026.
DEEP DIVE
IPO
Ingenic Semiconductor Launches $410M Hong Kong IPO
IPO$410M
Ingenic Semiconductor Launches $410M Hong Kong IPO
Beijing-based fabless chipmaker Ingenic Semiconductor launched a Hong Kong share offering to raise up to $410 million, joining a wave of mainland Chinese chip companies tapping Hong Kong's capital markets for international expansion.
DEEP DIVE
IPO
EquityZen's Haslett on the AI-vs-SaaS Secondary Divide
IPO
EquityZen's Haslett on the AI-vs-SaaS Secondary Divide
EquityZen's Phil Haslett says private-market secondaries now trade at an average 38% discount to last funding round, but AI-native startups from 2023 onward are pricing at premiums while 2021-vintage SaaS names sell at steep markdowns.
DEEP DIVE
IPO
Oura Eyes September IPO at $16B-Plus Valuation
IPO
Oura Eyes September IPO at $16B-Plus Valuation
Smart ring maker Oura is reportedly planning a US IPO as soon as September that could raise up to $3 billion and value the company above $16 billion, roughly 50% higher than its valuation less than a year ago.
DEEP DIVE
IPO
Heyer Brothers File S-1 for Haymaker SPAC No. 5
IPO
Heyer Brothers File S-1 for Haymaker SPAC No. 5
Steven and Andrew Heyer filed an S-1 for Haymaker Acquisition Corp V, their fifth consumer-focused blank-check company after prior SPACs that took OneSpaWorld, ARKO and Biote public.
DEEP DIVE
IPO
Polar Power Files New S-1 for DC Systems Maker
IPO
Polar Power Files New S-1 for DC Systems Maker
Polar Power, a Gardena, California maker of DC power and hybrid solar systems for telecom, military and off-grid customers, filed a new S-1 registration with the SEC on August 24, 2026.
DEEP DIVE
IPO
Live Oak Merchant Files S-1 for Sixth SPAC Vehicle
IPO
Live Oak Merchant Files S-1 for Sixth SPAC Vehicle
Live Oak Merchant Partners filed an S-1 for Live Oak Acquisition Corp VI, its sixth blank-check company, after prior vehicles took Danimer Scientific and Navitas Semiconductor public and merged Live Oak V with Teamshares in June.
DEEP DIVE
IPO
Trump Bought SpaceX Shares Weeks After Its Blockbuster IPO
IPO
Trump Bought SpaceX Shares Weeks After Its Blockbuster IPO
President Trump purchased SpaceX shares roughly two weeks after the company's blockbuster IPO, a disclosure that raises fresh conflict-of-interest questions given SpaceX's extensive federal contracts.
DEEP DIVE
IPO
Oura Eyes September IPO at $16B+ Valuation
IPO$16B+ valuation
Oura Eyes September IPO at $16B+ Valuation
Smart-ring maker Oura is reportedly preparing a US IPO as soon as September that could raise up to $3 billion at a valuation above $16 billion, nearly 50% above the $11 billion mark it carried after an $875 million round last year.
DEEP DIVE
IPO
Serina Therapeutics Files to Sell Shares for Parkinson's Drug
IPO
Serina Therapeutics Files to Sell Shares for Parkinson's Drug
Biotech Serina Therapeutics filed an S-1 covering up to 12.5 million shares tied to a stock purchase agreement, funding continued development of its lead Parkinson's disease candidate SER-252 built on its POZ drug-delivery platform.
DEEP DIVE
IPO
Polar Power Files S-1 as Off-Grid Demand Grows
IPO
Polar Power Files S-1 as Off-Grid Demand Grows
Polar Power, a Gardena, California maker of DC power systems for telecom towers, defense sites and off-grid installations, filed an amended S-1, its second registration statement in under a month.
BY THE NUMBERS
IPO
Miami Beach's NextNRG Files S-1 for Mobile Fuel Delivery
IPO
Miami Beach's NextNRG Files S-1 for Mobile Fuel Delivery
NextNRG, a Miami Beach-based on-demand and subscription mobile fuel delivery company led by CEO Michael Farkas, filed a new Form S-1 on August 24 alongside a Series C preferred stock issuance, as its fleet-fueling business scales.
DEEP DIVE
IPO
Shein Targets a $26 Billion IPO Valuation
IPO$26B
Shein Targets a $26 Billion IPO Valuation
Shein expects to price its long-delayed listing at a valuation around $26 billion, well below the $66 billion mark it carried in its 2023 private round.
DEEP DIVE
IPO
Nine New SEC Filings Test a Crowded IPO Calendar
IPO
Nine New SEC Filings Test a Crowded IPO Calendar
Nine new SEC registration statements filed August 24, spanning energy, biotech, minerals and blank-check issuers, show smaller companies still testing public markets this week.
DEEP DIVE
IPO
Five New S-1 Filings Show the IPO Window Stays Open
IPO
Five New S-1 Filings Show the IPO Window Stays Open
A fresh batch of SEC S-1 filings spanning energy, biotech and blank-check issuers shows smaller companies continuing to test the public market even as headline IPO attention stays on mega-cap listings.
BY THE NUMBERS
IPO
GridAI Technologies Amends S-1 for Grid Software Listing
IPO
GridAI Technologies Amends S-1 for Grid Software Listing
GridAI Technologies Corp has amended its S-1 to pursue a public listing for its AI-driven grid management software, betting utilities will pay for automated load-balancing as data-center demand strains capacity.
DEEP DIVE
IPO
Unitree's 460% IPO Pop Was Normal for China
IPO
Unitree's 460% IPO Pop Was Normal for China
Unitree's robot maker debut surged 460% on its first day, an outcome that reflects the structure of Chinese IPO pricing rules more than unique enthusiasm for the company.
DEEP DIVE
IPO
Nvidia and Salesforce Earnings Take the Spotlight
IPO
Nvidia and Salesforce Earnings Take the Spotlight
Nvidia and Salesforce report into a market that has grown skeptical of AI capex, making guidance more consequential than the quarters themselves.
DEEP DIVE
IPO
Holtec Nuclear Amends S-1 as SMR Demand Meets AI Power
IPO
Holtec Nuclear Amends S-1 as SMR Demand Meets AI Power
Holtec Nuclear Corp has amended its S-1 filing as small modular reactor developers ride growing data-center power demand into the public markets.
DEEP DIVE
IPO
Anthropic and OpenAI's Parallel Paths to Going Public
IPO
Anthropic and OpenAI's Parallel Paths to Going Public
Anthropic and OpenAI both have draft S-1s in motion, but their public postures differ sharply -- Anthropic racing toward a size comparable to SpaceX, OpenAI's CFO explicitly declining to treat the process as a race.
DEEP DIVE
IPO
Anthropic's IPO Filing Will Flag AI Backlash as Risk
IPO
Anthropic's IPO Filing Will Flag AI Backlash as Risk
Anthropic's forthcoming IPO filing will include AI backlash -- public and regulatory skepticism toward the industry -- as a formal risk factor, sources tell CNBC, an unusually candid disclosure for a company chasing SpaceX's record size.
FOLLOW-UP
IPO
Anthropic Eyes IPO Big Enough to Beat SpaceX
IPO
Anthropic Eyes IPO Big Enough to Beat SpaceX
Anthropic is preparing to file publicly for an IPO it expects to match or exceed SpaceX's record-setting size, with some investors modeling a valuation above $2 trillion.
DEEP DIVE
IPO
2026 US IPO Volume Nears the 2021 Record
IPO
2026 US IPO Volume Nears the 2021 Record
US companies have raised roughly $160.6 billion in IPO proceeds through August 19, putting 2026 within reach of 2021's full-year record of $175 billion even before Anthropic's own listing is counted.
DEEP DIVE
IPO
Three Biotechs File S-1s in the Same Week
IPO
Three Biotechs File S-1s in the Same Week
Tempest Therapeutics, Aptevo Therapeutics and Alzamend Neuro all filed S-1 registration statements this week, a reminder that the biotech IPO pipeline keeps moving even in a news cycle dominated by trillion-dollar AI listings.
DEEP DIVE
IPO
Three SPACs File This Week Hunting for Targets
IPO
Three SPACs File This Week Hunting for Targets
Dune Acquisition Corp III, Albatross Acquisition Corp and Three Lions Acquisition Corp all filed amended S-1 registrations this week, adding to a modest but real pipeline of blank-check vehicles still working through the SEC process.
DEEP DIVE
IPO
Defense Tech's Private Funding Boom Builds Toward IPOs
IPO
Defense Tech's Private Funding Boom Builds Toward IPOs
Crunchbase's roundup of this week's biggest funding rounds shows defense tech and AI infrastructure leading private capital deployment, increasingly feeding a public defense-tech IPO pipeline rather than staying purely private.
DEEP DIVE
IPO
The Defense-Space IPO Ladder, By the Numbers
IPO
The Defense-Space IPO Ladder, By the Numbers
This week's Castelion, Lyntris and Gravitics numbers together show a wide split in how public and private markets are pricing defense and space companies at almost the same moment.
BY THE NUMBERS
IPO
Where 2026's Record IPO Money Is Actually Landing
IPO
Where 2026's Record IPO Money Is Actually Landing
Break 2026's roughly $160B in IPO proceeds down by sector and it's concentrated in a handful of mega-deals -- space, AI and defense -- while smaller biotech, SPAC and fintech listings continue at a steadier pace underneath.
DEEP DIVE
IPO
2026's SPAC Comeback, Read Through Three Deals
IPO
2026's SPAC Comeback, Read Through Three Deals
Three SPAC deals in as many weeks -- Karman Line's blank-check filing, FORT Robotics' $557M merger, and a new physical-AI safety category -- show the SPAC structure quietly finding real footing again in defense and robotics.
DEEP DIVE
IPO
Why I'm Wary of This Week's Pre-Revenue IPO Rush
IPO
Why I'm Wary of This Week's Pre-Revenue IPO Rush
Gravitics is reaching Nasdaq with zero revenue via reverse merger the same week Castelion raised private capital at 26x contracted revenue -- a pattern worth pushing back on before it becomes the default path for hardware startups.
TRACE'S TAKE
IPO
Nvidia's Investment Pullback Is a Signal for 2026's IPO Class
IPO
Nvidia's Investment Pullback Is a Signal for 2026's IPO Class
Jensen Huang has signaled Nvidia's stakes in OpenAI and Anthropic are likely its last private investments in either company -- a strategic recalibration ahead of both labs' expected public listings, not a vote of declining confidence.
DEEP DIVE
IPO
Why I'd Rather Back the Acquirer Than Wait for the IPO
IPO
Why I'd Rather Back the Acquirer Than Wait for the IPO
Between Stripe buying OpenRouter and SpaceX buying Anysphere, $67.5B moved through M&A in six weeks. Anthropic's IPO won't price until November at the earliest. As an early check-writer, I'd rather back the company doing the buying.
TRACE'S TAKE
IPO
What This Week's IPO Slate Says About Small-Cap Tech
IPO
What This Week's IPO Slate Says About Small-Cap Tech
Thursday's stock slide didn't stop 7 IPOs from pricing the same day, including Lyntris' downsized defense-sector debut -- a sign the IPO window is staying open even as broader indices wobble on rate concerns.
DEEP DIVE
IPO
Why 2026's IPO Pipeline Is Running at Its Fastest Pace in Years
IPO
Why 2026's IPO Pipeline Is Running at Its Fastest Pace in Years
The week of August 16-22 alone saw 11 IPO pricings Monday, 6 Tuesday, 7 Wednesday, 7 Thursday and 4 more scheduled Friday -- 35 pricings in a single week, the clearest sign yet that the IPO window has genuinely reopened.
BY THE NUMBERS
IPO
Why Anthropic's IPO Math Points to a $1T+ Debut
IPO
Why Anthropic's IPO Math Points to a $1T+ Debut
Anthropic confidentially filed its S-1 on June 1 targeting a November 30 pricing, off a $965B Series H and $47B run-rate revenue -- market forecasters put the median 90-day post-IPO market cap at $1.14 trillion.
DEEP DIVE
IPO
SpaceX Stock Falls Below IPO Price on Share Unlock
IPO
SpaceX Stock Falls Below IPO Price on Share Unlock
SpaceX shares fell as much as 6% and dropped below their $135 IPO price after 319 million more shares became tradable, erasing roughly $103B of the company's implied market value in a single day.
DEEP DIVE
IPO
Gravitics Sets Terms for $125M Space-Station IPO
IPO$125M IPO
Gravitics Sets Terms for $125M Space-Station IPO
Space-infrastructure company Gravitics set terms for a $125M Nasdaq listing via reverse merger, aiming to build private space station modules despite zero revenue and a $24.5M six-month net loss.
DEEP DIVE
IPO
Rebellions Bets on a Korea IPO as Nvidia Circles
IPO
Rebellions Bets on a Korea IPO as Nvidia Circles
Rebellions' CFO calls a Korea Exchange listing the company's top priority, even as Nvidia opens early talks about a possible investment in or acquisition of the same $2.3B AI chipmaker.
DEEP DIVE
IPO
Castelion Hits $13B Valuation to Mass-Produce Missiles
IPO$1B Series C at $13B
Castelion Hits $13B Valuation to Mass-Produce Missiles
Defense startup Castelion raised a $1B Series C co-led by Andreessen Horowitz, Carlyle and JPMorgan at a $13B valuation to mass-produce hypersonic missiles in New Mexico, as the Pentagon races to close a stockpile gap with China.
DEEP DIVE
IPO
Airwallex Bets on Autonomous Finance, Delays IPO Timing
IPO$11B valuation (July raise)
Airwallex Bets on Autonomous Finance, Delays IPO Timing
Airwallex is repositioning from cross-border payments into an AI-native financial operating system focused on autonomous finance, while president Lucy Liu says it still targets IPO-readiness by year-end.
DEEP DIVE
IPO
OpenAI 'Will Be a Public Company in 2027,' CFO Tells Staff
IPO
OpenAI 'Will Be a Public Company in 2027,' CFO Tells Staff
OpenAI CFO Sarah Friar told employees at an all-hands meeting the company will be public by 2027 or sooner, framing the IPO as a fundraising milestone rather than a finish line, while acknowledging Anthropic could go public first.
DEEP DIVE
IPO
Cerebras Faces Its Own Lockup Cliff Before September
IPO
Cerebras Faces Its Own Lockup Cliff Before September
Up to 84 million Cerebras Class B shares become eligible to convert and sell by the end of August, almost three times the company's current public float, with another 87 million unlocking in September and October.
FOLLOW-UP
IPO
ServiceNow's $7.75B Armis Deal Bucks 'Saaspocalypse' Fears
IPO$7.75B acquisition
ServiceNow's $7.75B Armis Deal Bucks 'Saaspocalypse' Fears
ServiceNow's stock fell 42% in early 2026 on fears AI agents would make enterprise software obsolete, but its $7.75B acquisition of cybersecurity startup Armis helped drive a 41% May rally and outperformance versus Salesforce and Workday.
DEEP DIVE
IPO
Sequoia, Khosla, Y Combinator Lead 2026's Unicorn Class
IPO
Sequoia, Khosla, Y Combinator Lead 2026's Unicorn Class
Sequoia Capital, Khosla Ventures and Y Combinator top the list of investors backing 2026's new unicorns, with 250 companies reaching billion-dollar valuations through August 15 -- up from 193 in all of 2025, per Crunchbase data.
DEEP DIVE
IPO
Unitree Robotics Rockets 629% in Shanghai Trading Debut
IPO$904M raised, 629% debut pop
Unitree Robotics Rockets 629% in Shanghai Trading Debut
Unitree Robotics surged as much as 629% in its Shanghai debut, briefly hitting a $66B valuation before settling up 460% at roughly $47B, becoming the first humanoid robot maker listed in mainland China.
FOLLOW-UP
IPO
Lyntris Prices IPO Below Range at $17.50 a Share
IPO$297.5M raised at $17.50
Lyntris Prices IPO Below Range at $17.50 a Share
Defense-tech roll-up Lyntris priced its IPO at $17.50 a share, below the $19-$22 target range, raising roughly $297.5 million ahead of its NYSE debut under ticker LYNX -- a real-time gut check on defense-tech IPO demand after weeks of bullish sector coverage.
DEEP DIVE
IPO
Peacock Raises Prices 18% Right After Turning a Profit
IPO$17 to $20 ad-free
Peacock Raises Prices 18% Right After Turning a Profit
Peacock raised prices across all tiers for the fourth time in four years, months after posting its first quarterly profit of $189 million in adjusted EBITDA, with the ad-free plan going from $17 to $20 a month.
DEEP DIVE
IPO
Fort Robotics to Go Public in $557M SPAC Deal
IPO$557M enterprise value
Fort Robotics to Go Public in $557M SPAC Deal
Fort Robotics, a Mark Cuban-backed safety-infrastructure company for autonomous machines, agreed to go public via SPAC at a $557 million enterprise value -- the first public company built specifically for physical-AI safety.
DEEP DIVE
IPO
Nvidia's Moat Moves From Silicon to Its Balance Sheet
IPO$500B financing pact
Nvidia's Moat Moves From Silicon to Its Balance Sheet
With AMD and Google narrowing Nvidia's technology lead, the company is deploying its balance sheet instead -- a $500 billion GPU financing pact with Wall Street, a $105 billion OpenAI backstop and $30.2 billion in equity holdings.
DEEP DIVE
IPO
Tesla Readies a Public Cybercab Launch in Austin
IPO
Tesla Readies a Public Cybercab Launch in Austin
Tesla is planning a public launch of the Cybercab in Austin as soon as this month, according to The Information, though the two-seater without a steering wheel or pedals has often been spotted testing with both installed.
DEEP DIVE
IPO
Rare-Earth Miner Tactical Resources Hits Nasdaq
IPO
Rare-Earth Miner Tactical Resources Hits Nasdaq
Tactical Resources began trading on the Nasdaq under ticker TREO on August 18 via a SPAC merger with Plum Acquisition Corp. III, positioning the company to process rare-earth tailings in Texas as US critical-minerals policy intensifies.
DEEP DIVE
IPO
Kraken's Krak App Launches a 2% Cash-Back Debit Card
IPOUp to 2% cash back
Kraken's Krak App Launches a 2% Cash-Back Debit Card
Kraken's Krak money app launched a US debit card paying up to 2% back in cash or bitcoin, spendable from more than 600 currencies and crypto assets converted at the point of purchase.
DEEP DIVE
IPO
SpaceX Tows an Intact Starship to Christmas Island
IPO
SpaceX Tows an Intact Starship to Christmas Island
SpaceX recovered an intact Starship after a 24-day tow across the Indian Ocean to Christmas Island, the first time a ship survived splashdown without disintegrating and the first chance to inspect flown heat shield hardware.
DEEP DIVE
IPO
Two New Aerospace SPACs Price $300M in Combined IPOs
IPO$300M
Two New Aerospace SPACs Price $300M in Combined IPOs
Karman Line Acquisition Corp and NorthStrive Acquisition Corp I priced a combined $300 million in blank-check IPOs targeting aerospace, defense and industrial manufacturing.
DEEP DIVE
IPO
Pony AI's Robotaxi Revenue Jumps 691% in Q2
IPORobotaxi rev. $12.1M, +691%
Pony AI's Robotaxi Revenue Jumps 691% in Q2
Pony AI reported Q2 revenue up 69% to $36.2 million, with robotaxi service revenue up 691% to a record $12.1 million as its fleet grew to 2,000 vehicles and Uber committed to more than 4,000 robotaxis across international markets including Europe.
DEEP DIVE
IPO
ECB Economists Say an AI Valuation Correction Is Likely
IPO
ECB Economists Say an AI Valuation Correction Is Likely
European Central Bank economists wrote that research on past technological revolutions points to a likely correction in current stock valuations, with the drawdown arriving whether or not investors are being irrational about AI.
DEEP DIVE
IPO
Korean Retail Investors Pile Into US Stocks
IPO$4.5B in July
Korean Retail Investors Pile Into US Stocks
South Korean retail investors made $4.5 billion in net purchases of US securities in July, part of $73.6 billion in 2025 alone, as domestic market volatility pushes 'ant investors' toward US equities and leveraged semiconductor ETFs.
DEEP DIVE
IPO
CXMT's Rise to China's Most Valuable Firm, Explained
IPO$524B market cap
CXMT's Rise to China's Most Valuable Firm, Explained
Memory chipmaker CXMT overtook Tencent as China's most valuable listed company just weeks after a 466% IPO debut, putting a number on how central memory chips have become to China's AI buildout.
DEEP DIVE
IPO
OpenAI's Revenue Run-Rate Doubles to $40B Pre-IPO
IPO$40B run-rate
OpenAI's Revenue Run-Rate Doubles to $40B Pre-IPO
OpenAI's revenue run-rate has topped $40 billion, roughly double where it stood at the end of 2025, sharpening the case for its Wall Street debut even as the risks Pulse flagged in its IPO warning coverage remain unresolved.
FOLLOW-UP
IPO
The IPO Window Is Open for Four Companies, Not Forty
IPO
The IPO Window Is Open for Four Companies, Not Forty
The 2026 tech listing boom is real in aggregate and concentrated in practice: a handful of megacap names carry the volume while the median venture-backed company still cannot clear the bar underwriters are setting.
TRACE'S TAKE
IPO
AI's Best Exits Are Trades, Not Listings
IPO$7B+ largest AI trade sale
AI's Best Exits Are Trades, Not Listings
Stripe's $7 billion purchase of OpenRouter, SpaceX's Cursor deal and consolidation among eVTOL makers point to strategic acquisition replacing the public offering as the primary liquidity path for AI-era companies.
DEEP DIVE
IPO
Reddit Joins the S&P 500 on a Stunning Turnaround
IPO$29.5B market cap
Reddit Joins the S&P 500 on a Stunning Turnaround
Reddit joins the S&P 500 before markets open on August 18, becoming only the second pure-play social media company in the index after Meta, following a stock rally triggered by the inclusion announcement.
DEEP DIVE
IPO
This Week's IPO Filings Are Mostly Small Shells
IPO
This Week's IPO Filings Are Mostly Small Shells
Eight S-1-family filings hit the SEC between August 13 and 17, and none are venture-scale tech debuts -- a reminder that most weeks in an active IPO year still produce shell registrations and small financials, not headline listings.
BY THE NUMBERS
IPO
What's Left in the 2026 IPO Pipeline
IPO
What's Left in the 2026 IPO Pipeline
SpaceX's $1.77 trillion June debut made Q2 2026 the biggest quarter for U.S. IPOs on record, and OpenAI and Anthropic are both racing toward their own public listings before year-end -- the two biggest names left in a pipeline that's otherwise thinning out.
BY THE NUMBERS
IPO
Cooling Inflation, Intel Raise Lift the AI Trade
IPO
Cooling Inflation, Intel Raise Lift the AI Trade
A cooler-than-expected inflation report and Intel upsized $20 billion stock sale helped push the odds of a Fed hold at the September meeting to 67%, up from 55%, a backdrop that matters for how pending mega-IPOs get priced this fall.
DEEP DIVE
IPO
The 2026 IPO Class Scorecard: Who's Actually Winning
IPO
The 2026 IPO Class Scorecard: Who's Actually Winning
A hot IPO window doesn't guarantee a hot stock afterward -- Cerebras is down sharply on its second earnings report even after raising guidance, while Reddit and SanDisk show post-listing performance hinges on execution, not debut pricing.
DEEP DIVE
IPO
US IPO Proceeds Are Running 7x Ahead of 2025
IPO$114.1B raised YTD
US IPO Proceeds Are Running 7x Ahead of 2025
SEC data shows traditional US IPOs raised roughly $114.1 billion through June 30, more than seven times the $14.8 billion raised over the same period in 2025, spread across AI infrastructure, industrials, healthcare and consumer sectors.
BY THE NUMBERS
IPO
Anthropic Backers Model a $2-3 Trillion October IPO
IPO$2T-$3T (modeled)
Anthropic Backers Model a $2-3 Trillion October IPO
Anthropic investors are modeling a $2 trillion IPO valuation for October, with some projecting as high as $3 trillion, based on annualized revenue expected to reach $100 billion to $120 billion by year-end.
DEEP DIVE
IPO
SharonAI Amends IPO Filing as Neocloud IPO Wave Builds
IPO
SharonAI Amends IPO Filing as Neocloud IPO Wave Builds
SharonAI Holdings, an Australian neocloud operator partnering with Nvidia on GPU clusters, filed an amended S-1 registering $691.7 million in convertible notes and 26 million resale shares as it builds out AI data center capacity.
DEEP DIVE
IPO
Anthropic Reportedly Plans $2 Trillion IPO for October
IPO
Anthropic Reportedly Plans $2 Trillion IPO for October
Anthropic is preparing a stock listing that investors and bankers believe could value the company near $2 trillion as soon as October, the largest public offering in history and more than double its last private mark of $965 billion.
DEEP DIVE
IPO
Six Companies Filed for US Listings This Week: The S-1 Rundown
IPO
Six Companies Filed for US Listings This Week: The S-1 Rundown
At least six companies filed IPO paperwork with the SEC on August 12, spanning AI infrastructure, biopharma, fintech and minerals -- a reminder the listing pipeline stays busy behind mega-IPO headlines like Anthropic's.
BY THE NUMBERS
IPO
Unitree's $9B IPO Subscription Closes, Debut Set for Late August
IPO~$900M raise at $9B valuation
Unitree's $9B IPO Subscription Closes, Debut Set for Late August
Unitree's STAR Market IPO subscription window closed Wednesday after pricing at 150.80 yuan a share and a $9 billion valuation, with the humanoid robot maker's Shanghai trading debut now expected between August 17 and 21.
FOLLOW-UP
IPO
Robinhood's YC-Linked Retail Fund Nears NYSE Debut
IPO
Robinhood's YC-Linked Retail Fund Nears NYSE Debut
Robinhood Ventures Fund II, a closed-end fund giving retail investors exposure to 80 early-stage startups linked to Y Combinator, closes its share-request window August 12 ahead of a planned NYSE debut at $25 a share on August 13.
DEEP DIVE
IPO
Chinese Copper Foil Maker Londian Wason Preps NYSE Debut
IPO$75M target
Chinese Copper Foil Maker Londian Wason Preps NYSE Debut
Londian Wason New Energy Tech, a Shenzhen-based electrolytic copper foil producer for EV batteries, set terms to raise $75 million on the NYSE under ticker FOIL, with pricing expected around August 12.
DEEP DIVE
IPO
Biotech IPO Window Closes Its Strongest Week Since Spring
IPO~$972M, 4 deals
Biotech IPO Window Closes Its Strongest Week Since Spring
BlossomHill and Latigo Biotherapeutics both closed upsized IPOs by August 10, capping a four-deal stretch that also included Braveheart Bio and Attovia Therapeutics pricing above or near the top of their ranges.
FOLLOW-UP
IPO
Unitree's STAR Market IPO Subscription Opens at $9B
IPO
Unitree's STAR Market IPO Subscription Opens at $9B
Unitree's Shanghai STAR Market IPO subscription formally opened at a roughly $9 billion valuation, the first profitable, scaled humanoid robotics company to go public on a major exchange.
FOLLOW-UP
IPO
Attovia Therapeutics Climbs 29% After $289M IPO
IPO$289M IPO
Attovia Therapeutics Climbs 29% After $289M IPO
Attovia Therapeutics priced an upsized $289 million IPO and climbed 29% on debut, the fourth biotech in two weeks to price well above its original terms.
FOLLOW-UP
IPO
Caris Leads a Wild Week for Recent IPO Stocks
IPO
Caris Leads a Wild Week for Recent IPO Stocks
Caris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.
BRIEF
IPO
BillionToOne's Selloff Is a Warning for Biotech IPOs
IPO
BillionToOne's Selloff Is a Warning for Biotech IPOs
BillionToOne beat Q2 estimates by a wide margin and still fell nearly 30% because it reiterated rather than raised guidance -- a signal about how little room newly public companies have left to disappoint.
TRACE'S TAKE
IPO
What BofA's Extreme Bull Signal Means for Your Marks
IPO
What BofA's Extreme Bull Signal Means for Your Marks
BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.
TRACE'S TAKE
IPO
Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined
Biotech IPOs Are Pricing Above Range Again
BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.
BY THE NUMBERS
IPO
Latigo Biotherapeutics Jumps 17% in $345.6M IPO
IPO$345.6M IPO
Latigo Biotherapeutics Jumps 17% in $345.6M IPO
Latigo Biotherapeutics priced its upsized IPO at $18 a share for $345.6 million and jumped 17% in its Nasdaq debut, the third biotech offering in two weeks to price above range.
FOLLOW-UP
IPO
Wall Street Rallies on Weak Jobs Data as Software Earnings Beat
IPO
Wall Street Rallies on Weak Jobs Data as Software Earnings Beat
A weak July jobs report sent stocks to a broad rally on rate-cut bets, with Atlassian and Twilio posting blowout earnings beats -- even as Bank of America's own sentiment gauge hit its most bullish reading since 2021.
DEEP DIVE
IPO
SpaceX Swings From Post-Earnings Drop to 16% Rally
IPO$7.81B Q2 revenue
SpaceX Swings From Post-Earnings Drop to 16% Rally
SpaceX stock fell 8% after a Q2 earnings beat spooked investors on capex, then rallied 15.83% three days later as its first lockup expiration passed without heavy selling and the Cursor deal stayed on track.
BRIEF
IPO
BofA's Sell Signal Hits Highest Level Since 2021
IPO
BofA's Sell Signal Hits Highest Level Since 2021
Bank of America's Bull & Bear sentiment indicator jumped to 9.7 -- its highest reading since 2021 and above the firm's own 8.0 sell-signal threshold -- even as the S&P 500 and Nasdaq both rallied Friday on weak jobs data.
BRIEF
IPO
Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat
IPO+35.6% stock move
Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat
Atlassian shares surged as much as 35.6% after fiscal Q4 revenue beat estimates by $100M+ on 31% cloud growth, with co-founder Mike Cannon-Brookes pledging to personally buy up to $250M of stock.
BRIEF
IPO
Cloudflare Stock Jumps 15% on Earnings Beat
IPO
Cloudflare Stock Jumps 15% on Earnings Beat
Cloudflare shares jumped as much as 17% after beating Q2 estimates and raising full-year guidance, with AI-driven demand for network security and infrastructure cited as the key growth driver.
BRIEF
IPO
BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO
BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.
FOLLOW-UP
IPO
Braveheart Bio Prices Upsized $382.5M IPO on Nasdaq
IPO$382.5M IPO
Braveheart Bio Prices Upsized $382.5M IPO on Nasdaq
Braveheart Bio priced its IPO at $18 a share, above range, raising $382.5M for a cardiovascular drug licensed from China's Hengrui Pharmaceuticals -- a sign the biotech IPO window is reopening after two rough years.
BRIEF
IPO
SpaceX's Rocky Unlock Is a Warning for OpenAI
IPO
SpaceX's Rocky Unlock Is a Warning for OpenAI
SpaceX shares are trading near $108, down more than half from their post-IPO high, just as the first of four straight monthly unlock events begins -- a live case study for OpenAI and Anthropic on what happens once lockups start expiring.
BY THE NUMBERS
IPO
Unitree Prices IPO at $9B on Shanghai Market
IPO$904M IPO, ~$9B valuation
Unitree Prices IPO at $9B on Shanghai Market
Unitree Robotics priced its Shanghai STAR Market IPO at 150.80 yuan a share, raising roughly $904 million and valuing China's first publicly traded humanoid robot maker at about $9 billion.
BRIEF
IPO
SK Hynix Plunges 10% in Asian Tech Selloff
IPO
SK Hynix Plunges 10% in Asian Tech Selloff
SK Hynix fell nearly 10% and Samsung dropped over 6% as Asian tech stocks tracked a Wall Street AI-name selloff, the second sharp chip-sector drop in the Korean chipmaker's shares in two weeks.
BRIEF
IPO
Vogenx Prices $68M IPO for Metabolic Drug
IPO~$67.8M net
Vogenx Prices $68M IPO for Metabolic Drug
Vogenx priced 6.25M shares at $12 to raise roughly $68M net, funding development of mizagliflozin, an SGLT1 inhibitor for gastrointestinal and metabolic disorders, through 2028.
IPO
Braveheart Bio Prices $300M IPO for Heart Drug
IPO$300M IPO
Braveheart Bio Prices $300M IPO for Heart Drug
Braveheart Bio priced 18.75M shares at $16 to raise $300M on Nasdaq, funding its lead drug BHB-1893 for hypertrophic cardiomyopathy in the same week two other biotechs also priced.
IPO
Figma Stock Drops 16% Despite Revenue Beat
IPO-16.5% stock move
Figma Stock Drops 16% Despite Revenue Beat
Figma shares fell as much as 16.5% after Q2 revenue beat estimates at $370M but rising AI infrastructure costs and the departure of two senior executives overshadowed a raised full-year outlook.
BRIEF
IPO
SPAC Pipeline Grows With Two More Filings
IPO
SPAC Pipeline Grows With Two More Filings
Gravity Acquisition Corp continued toward its own listing and Alternus Clean Energy issued $14.28M of preferred stock ahead of a planned uplisting, extending the blank-check filing wave Pulse flagged earlier this week.
FOLLOW-UP
IPO
Why 217 IPOs Still Doesn't Mean the Window Is Open
IPO217 IPOs YTD
Why 217 IPOs Still Doesn't Mean the Window Is Open
The US has produced 217 IPOs in 2026, up 6.9% year over year, and almost none of them are venture-backed technology companies -- which is why the count says nothing useful about exit liquidity.
IPO
AMD Beats Estimates, Stock Falls on Musk's Nvidia Bet
IPO
AMD Beats Estimates, Stock Falls on Musk's Nvidia Bet
AMD's Q2 results beat consensus and CEO Lisa Su guided to 80% server revenue growth in the second half, but shares fell after Elon Musk said SpaceX would commit fully to Nvidia chips for its AI infrastructure.
IPO
Goldman-Backed Attovia Prices IPO, Lists on Nasdaq
IPO~$212.5M raised
Goldman-Backed Attovia Prices IPO, Lists on Nasdaq
Attovia Therapeutics priced its IPO at $17/share, raising roughly $212.5M, and began trading on Nasdaq today under ATTO -- another test of whether biotech's IPO window is genuinely reopening.
IPO
Seven Blank-Check Deals Hit the Market in Three Days
IPO$10 per unit
Seven Blank-Check Deals Hit the Market in Three Days
Between August 3 and August 5, three SPACs priced at $10 a unit and four more filed or amended registration statements with the SEC -- the densest run of blank-check activity of the summer.
IPO
Uber Beats Q2 Bookings, Guides Q3 Below Estimates
IPO$58B Q2 bookings
Uber Beats Q2 Bookings, Guides Q3 Below Estimates
Uber's Q2 gross bookings of $58B topped estimates, but Q3 guidance for both bookings and EPS came in below consensus, sending shares down about 4%.
IPO
Attovia Prices $289M Nasdaq IPO at $17 a Share
IPO$289M IPO
Attovia Prices $289M Nasdaq IPO at $17 a Share
Attovia Therapeutics priced 17 million shares at $17 to raise $289M on Nasdaq under the ticker ATTO, the largest operating-company listing of the first week of August.
IPO
Uber Issues Weaker Q3 Outlook Despite Bookings Beat
IPO$14.19B Q2 revenue
Uber Issues Weaker Q3 Outlook Despite Bookings Beat
Uber's Q2 gross bookings beat estimates on World Cup travel demand, but Q3 bookings and earnings guidance came in below Wall Street's forecast, sending shares down more than 4% premarket.
IPO
Uber CEO Dismisses Reports of a Waymo Split
IPO
Uber CEO Dismisses Reports of a Waymo Split
Dara Khosrowshahi pushed back on reports that Uber and Waymo are heading for a breakup, on the same day Uber's stock fell on soft forward guidance and Zoox announced paid robotaxi rides in Las Vegas.
IPO
S&P 500, Stoxx 600 Both Hit Record Highs
IPOS&P 500: 7,737
S&P 500, Stoxx 600 Both Hit Record Highs
The S&P 500 closed at its first record high in two months and the Stoxx 600 touched an all-time high, both propelled by strong earnings and renewed AI-trade optimism despite this week's capex-driven sell-offs.
IPO
D-Wave Publishes a Quantum Error-Correction Advance
IPO
D-Wave Publishes a Quantum Error-Correction Advance
D-Wave published Nature research showing a fast, high-fidelity entangling gate for its dual-rail superconducting qubits, with simulations suggesting up to a tenfold cut in logical error rates per correction increment.
IPO
Robinhood Lists a Fund That Buys Y Combinator Stakes
IPO$200M target raise
Robinhood Lists a Fund That Buys Y Combinator Stakes
Robinhood Ventures Fund II is set to list publicly on August 13 at $25 a share, aiming to raise $200M so retail investors can indirectly back roughly 80 Y Combinator-linked private companies -- while paying Robinhood 2% and 20% carry.
IPO
Stoxx 600 Hits a Record as European Equities Rally
IPO
Stoxx 600 Hits a Record as European Equities Rally
Europe's benchmark index set an all-time high, extending a global equity rally that also carried the S&P 500 and Dow to records this week on strong earnings and easing oil prices.
IPO
SpaceX's $1T Dream Meets Its First Insider Lockup Test
IPO
SpaceX's $1T Dream Meets Its First Insider Lockup Test
Roughly 911.5 million SpaceX shares become eligible for sale as insider lockups expire this week, a real supply test for a stock already down nearly half from its June IPO peak.
IPO
SoftBank Jumps as Asia Tech Tracks AI Rally
IPO
SoftBank Jumps as Asia Tech Tracks AI Rally
SoftBank shares surged more than 10% as Asian tech stocks tracked a strong Wall Street rally, with Arm's chip royalty optimism and gains at SK Hynix and Samsung all contributing.
IPO
SoftBank Surges 14% as Asia Tech Rallies
IPO+13.96% SoftBank
SoftBank Surges 14% as Asia Tech Rallies
SoftBank jumped nearly 14% and the KOSPI and Nikkei both rose more than 3.6% as Asian tech stocks tracked Wall Street's record-setting AI-fueled session.
IPO
Pinterest Beats Q2, Falls 8% on Soft Q3 Outlook
IPO-8.3% after hours
Pinterest Beats Q2, Falls 8% on Soft Q3 Outlook
Pinterest topped Q2 revenue and EPS estimates, but shares fell more than 8% in after-hours trading after Q3 guidance came in below what investors wanted to see.
IPO
Pinterest Beats the Quarter, Falls 7% on Guidance
IPO$1.18B Q2 revenue
Pinterest Beats the Quarter, Falls 7% on Guidance
Pinterest beat Q2 revenue and user growth estimates, but shares fell 7% after the company guided to Q3 revenue growth decelerating to 13-15% amid intensifying ad competition from Instagram.
IPO
SpaceX Beats in First Earnings Report Since IPO
IPO$7.81B Q2 revenue
SpaceX Beats in First Earnings Report Since IPO
SpaceX posted $7.81B in Q2 revenue, beating estimates by 13%, but shares swung after AI infrastructure capex hit $15.83B for the quarter, far above what analysts expected.
IPO
Attovia Prices IPO as Biotech's Public Pipeline Fills Out
IPO$17/share IPO
Attovia Prices IPO as Biotech's Public Pipeline Fills Out
Attovia Therapeutics priced its Nasdaq IPO at $17 a share while Latigo Biotherapeutics advances its own S-1, the latest signs that the biotech listing window is filling with genuine clinical-stage pipelines.
IPO
Lucid's Turnaround Bets on $1.4B in Savings and Robotaxis
IPO$1.4B cash-savings target
Lucid's Turnaround Bets on $1.4B in Savings and Robotaxis
Lucid launched an operational reset targeting $1.4B in 2026 cash savings, leaning on its Uber- and Nuro-linked robotaxi program as one of four priorities meant to fix a widening quarterly loss.
IPO
Tesla's China Business Is Its Cash Cow and Its Risk
IPO
Tesla's China Business Is Its Cash Cow and Its Risk
Ars Technica examines how much of Tesla's profitability still runs through China, and how quickly domestic Chinese EV makers are taking the share that funds it.
IPO
Palantir Revenue Jumps 93%, Stock Surges 29%
IPO$1.94B Q2 revenue
Palantir Revenue Jumps 93%, Stock Surges 29%
Palantir posted $1.94B in Q2 revenue, raised full-year guidance to roughly $8.15B, and watched its stock climb 29% in a single session as US commercial revenue grew 149% year over year.
IPO
Latigo Sets Terms for a $272M Nasdaq IPO
IPO$272M IPO
Latigo Sets Terms for a $272M Nasdaq IPO
Latigo Biotherapeutics set terms for a $272M Nasdaq IPO under ticker LTGO, pricing 16M shares at $16-18 to fund late-stage trials of its non-opioid Nav1.8 pain drug, a rival to Vertex's Journax.
IPO
What Circle's Trading Multiple Means for Coinbase
IPO
What Circle's Trading Multiple Means for Coinbase
Circle's stock trades well below its post-IPO peak even with USDC's volume growing, and that public multiple is the most direct read available on how the market is now pricing Coinbase's own stablecoin-dependent revenue.
IPO
Robotics' IPO Pipeline: Who's Actually Ready
IPO
Robotics' IPO Pipeline: Who's Actually Ready
Figure AI at a private $39B valuation and China's Unitree pursuing a Shanghai STAR Market listing represent two very different paths to a robotics IPO -- and neither looks genuinely ready by the disclosure standards Cerebras and SpaceX have just set.
IPO
The Nuclear-Chip IPO Pipeline Nobody's Pricing In
IPO
The Nuclear-Chip IPO Pipeline Nobody's Pricing In
Valar Atomics at a $6B private valuation and OLIX at $3.3B are both explicitly infrastructure bets, not software -- and neither has a clear public comp set yet, which means whoever lists first effectively prices the entire category.
IPO
Cerebras, Three Months Public: The Scorecard
IPO
Cerebras, Three Months Public: The Scorecard
Cerebras went public in May at a $56.43B implied valuation, becoming the market's clearest test case for whether a pure-play AI chip challenger to Nvidia can hold a premium multiple once quarterly numbers replace private-market narrative.
IPO
Tech's Biotech IPO Window Is Quietly Reopening
IPO
Tech's Biotech IPO Window Is Quietly Reopening
While tech IPOs grab headlines, this week's actual new listings are almost entirely biotech -- a sign the broader IPO window is widening beyond the handful of AI mega-caps everyone's watching.
IPO
The Anthropic-OpenAI IPO Race, Scored
IPO
The Anthropic-OpenAI IPO Race, Scored
Anthropic confidentially filed for IPO first, at a $965B valuation on a $47B revenue run rate -- but OpenAI's IPO pipeline is also active, and the two companies are now effectively racing to define what an AI-lab public listing should look like.
IPO
SpaceX Reports First Earnings as a Public Company Tuesday
IPO
SpaceX Reports First Earnings as a Public Company Tuesday
SpaceX posts its first-ever quarterly results Tuesday after market close, with Wall Street modeling roughly $6.88B in revenue -- the first real test of the $1.4T valuation the market has been pricing on faith since June.
IPO
BlossomHill Files for $100M Nasdaq IPO in Cancer Drugs
IPO$100M IPO target
BlossomHill Files for $100M Nasdaq IPO in Cancer Drugs
BlossomHill Therapeutics filed for a $100M Nasdaq IPO under ticker BLSM, adding an oncology-focused biotech with $257M in prior funding to a summer pipeline of clinical-stage listings led by J.P. Morgan, Leerink and Guggenheim.
IPO
Databricks' $188B Mark Gets a Retail-Adjacent Front Door
IPO
Databricks' $188B Mark Gets a Retail-Adjacent Front Door
Clear Street's new pre-IPO platform is opening accredited-investor access to $188B-valued Databricks through an SPV structure -- a preview of how late-stage AI names may get priced before they ever file an S-1.
IPO
Westinghouse's IPO Filing Is a Bet on AI's Power Problem
IPO
Westinghouse's IPO Filing Is a Bet on AI's Power Problem
Nuclear reactor supplier Westinghouse Electric confidentially filed for a US IPO, riding investor enthusiasm for nuclear power as Big Tech's AI datacenter buildout strains the grid.
IPO
Blue Owl-Backed Latigo Advances Nasdaq IPO Plans
IPO
Blue Owl-Backed Latigo Advances Nasdaq IPO Plans
Latigo Biotherapeutics filed an amended S-1 this week, advancing its Nasdaq IPO to fund a pivotal Phase 3 trial for its non-opioid pain drug ahead of the trial itself starting.
IPO
SpaceX's Earnings Week Is a Referendum on AI Valuations
IPO~$116B unlock
SpaceX's Earnings Week Is a Referendum on AI Valuations
SpaceX's first public earnings report and a roughly $116 billion lockup unlock land the same week the stock sits about 20% below its IPO price -- a live test of how much AI-era enthusiasm public markets will still pay for.
IPO
Coinbase's Circle Renewal Is a Preview of Crypto's IPO Math
IPO
Coinbase's Circle Renewal Is a Preview of Crypto's IPO Math
Coinbase renewing its Circle revenue-sharing deal even as trading revenue fell 19% for a third straight quarter shows crypto public companies leaning on stable, subscription-like income to offset volatile trading revenue.
IPO
Neoclouds Are Quietly Lining Up Behind SpaceX for IPOs
IPO
Neoclouds Are Quietly Lining Up Behind SpaceX for IPOs
Nscale hiring Goldman Sachs and JPMorgan for a possible late-2026 IPO, on the heels of a $14.6 billion private valuation and a $1.65 billion Anyscale acquisition, is an early look at the neocloud sector's own path toward public markets.
IPO
Consumer IPOs Are Getting Crushed While Biotech Pops
IPO
Consumer IPOs Are Getting Crushed While Biotech Pops
Jersey Mike's opened 9% below its IPO price the same day Reformation traded flat, while Apnimed popped 37.5% days later -- public investors are rewarding unmet-need biotech and discounting mature consumer brands.
IPO
The AI Lab IPO Race Is Now a Profitability Contest
IPO
The AI Lab IPO Race Is Now a Profitability Contest
With OpenAI and Anthropic both racing toward IPOs targeting valuations near $1 trillion, and OpenAI's own leadership reportedly expecting Anthropic to list first, public-market readiness increasingly hinges on profitability trajectory rather than raw scale.
IPO
Unitree's IPO Gives Humanoid Robotics a Real Price Tag
IPO
Unitree's IPO Gives Humanoid Robotics a Real Price Tag
Unitree's Shanghai IPO, with secondary-market chatter running toward $14.8 billion against a $6.2 billion base, is about to give the humanoid-robotics sector its first transparent public price -- a sharp contrast to Figure's opaque $39 billion private mark.
IPO
Why Musk's SpaceX Shares Stay Locked Until 2027
IPO
Why Musk's SpaceX Shares Stay Locked Until 2027
Elon Musk and a select group of SpaceX insiders remaining locked out of this week's share unlock until mid-2027, while other pre-IPO holders can sell, is a founder-alignment signal other AI-scale IPO candidates may want to copy.
IPO
Coinbase's Third Straight Down Quarter, With a Twist
IPO
Coinbase's Third Straight Down Quarter, With a Twist
Coinbase revenue fell 19% to $1.22B in a third consecutive quarterly decline, yet the company posted a record 10.3% share of global crypto trading volume -- shrinking revenue and growing market share at the same time.
IPO
Muted Consumer IPO Debuts Are a Warning for the Tech Pipeline
IPO
Muted Consumer IPO Debuts Are a Warning for the Tech Pipeline
Reformation and Jersey Mike's both priced and debuted within days of each other with muted first-day performance, a real-time read on risk appetite that every AI-adjacent IPO waiting in the wings should be watching closely.
IPO
Unitree's IPO Subscription Opens August 10 -- What Changed
IPO
Unitree's IPO Subscription Opens August 10 -- What Changed
Unitree set public subscription for August 10 on its Shanghai STAR Market IPO, offering 40.45 million shares, with first-half 2026 revenue guidance implying 35.6-45.4% year-over-year growth.
IPO
SpaceX Moves to Buy 130,000 Acres of Louisiana Marshland
IPO
SpaceX Moves to Buy 130,000 Acres of Louisiana Marshland
SpaceX is set to acquire roughly 130,000 acres of marshland in southern Louisiana, a major post-IPO capital deployment that lands the same week as its first public earnings report and lockup unlock.
IPO
Eric Trump-Backed Space-Eyes Bets Defense Tech on a SPAC
IPO
Eric Trump-Backed Space-Eyes Bets Defense Tech on a SPAC
Space-Eyes, a counter-drone and geospatial intelligence company backed by Eric Trump, agreeing to go public through a $638 million merger with McKinley Acquisition Corp shows blank-check listings finding real traction in defense tech, not just robotics.
IPO
A $100M SPAC IPO Signals Blank-Check Issuance Is Back
IPO
A $100M SPAC IPO Signals Blank-Check Issuance Is Back
East West Ave Acquisition Corp pricing a $100 million IPO targeting fintech, digital assets and energy deals is a small but real signal that blank-check issuance -- not just SPAC mergers -- is picking back up in 2026.
IPO
The US Just Blacklisted Foreign Humanoid Robots
IPO
The US Just Blacklisted Foreign Humanoid Robots
The US added foreign-made humanoid and quadruped robots to the FCC's national-security Covered List just days before Unitree's Shanghai IPO, effectively closing off what would otherwise be China's largest addressable robotics market.
IPO
What Unitree's Shanghai Listing Means for US Investors
IPO
What Unitree's Shanghai Listing Means for US Investors
Unitree Robotics choosing Shanghai's STAR Market over a US listing for its IPO is a clear example of how US-China tensions are pushing China's most valuable AI and robotics companies to list at home, cutting off ordinary US investors from direct access.
IPO
SpaceX's $116B Lockup Unlock Is a Bigger Test Than Earnings
IPO
SpaceX's $116B Lockup Unlock Is a Bigger Test Than Earnings
Starting August 6, up to 911.5 million SpaceX shares -- worth roughly $116B -- become eligible for sale in a staggered release, a supply event that dwarfs the stock's current public float.
IPO
Robinhood Now Makes More Money on Predictions Than Stocks
IPO
Robinhood Now Makes More Money on Predictions Than Stocks
Robinhood now generates more revenue from prediction markets than from traditional stock trading, a structural shift in its business mix that public-market investors are still working out how to price.
IPO
Biotech IPOs Are Upsizing Mid-Roadmap in 2026
IPO
Biotech IPOs Are Upsizing Mid-Roadmap in 2026
Several of 2026's biotech IPOs have expanded their target raise between initial filing and pricing, a sign the sector's strong average return this year has pulled in enough demand that bankers are re-cutting deal size on the fly.
IPO
SpaceX Leads a Genuinely Crowded Public-Markets Earnings Week
IPO
SpaceX Leads a Genuinely Crowded Public-Markets Earnings Week
SpaceX's first public earnings report anchors an unusually dense week of public-market disclosures across space, fintech and crypto, giving investors a rare same-week comparison of how differently AI-era companies are actually monetizing.
IPO
Why Robotics Is Quietly Becoming the SPAC Market's Favorite Exit
IPO
Why Robotics Is Quietly Becoming the SPAC Market's Favorite Exit
Between Agility Robotics' $2.5B SPAC merger and Michael Klein's newest blank-check vehicle, 2026's SPAC revival is being built on capital-intensive robotics and infrastructure, not the last cycle's meme stocks.
IPO
SPACs Are Quietly Having Their Best Stretch Since 2021
IPO
SPACs Are Quietly Having Their Best Stretch Since 2021
Three SPACs priced or announced deals in one week -- Churchill Capital XIII, East West Ave, and Space-Eyes' merger vehicle -- a pickup in blank-check issuance overshadowed by this week's AI mega-rounds.
IPO
The IPO Window Is Splitting Into Two Very Different Tiers
IPO
The IPO Window Is Splitting Into Two Very Different Tiers
This week's debuts split the 2026 IPO market sharply: differentiated biotech stories got double-digit pops, while mature, sponsor-backed consumer brands opened flat or down regardless of profitability.
IPO
Miami's Space-Eyes to Go Public in $638M SPAC Merger
IPO$638M
Miami's Space-Eyes to Go Public in $638M SPAC Merger
Space-Eyes, a Miami-based AI counter-drone and geospatial intelligence startup, will go public via a SPAC merger with McKinley Acquisition Corp at a $638 million equity value.
DEEP DIVE
IPO
Apnimed Soars 37% in Nasdaq Debut for Sleep Apnea Pill
IPO$192M IPO
Apnimed Soars 37% in Nasdaq Debut for Sleep Apnea Pill
Apnimed shares jumped as much as 37.5% in their Nasdaq debut after the Phase 3 biotech priced its upsized IPO at $16 a share, raising $192 million to fund what could become the first FDA-approved pill for obstructive sleep apnea.
IPO
East West Ave Prices $100M SPAC IPO on Nasdaq
IPO$100M SPAC IPO
East West Ave Prices $100M SPAC IPO on Nasdaq
East West Ave Acquisition Corp priced a $100 million IPO of 10 million units at $10 each, targeting fintech, digital assets and energy deal opportunities as blank-check listings continue picking up in 2026.
IPO
Eric Trump-Backed Space-Eyes to Go Public in $638M SPAC Deal
IPO$638M SPAC merger
Eric Trump-Backed Space-Eyes to Go Public in $638M SPAC Deal
Space-Eyes, a counter-drone and geospatial intelligence company backed by Eric Trump, agreed to go public through a merger with McKinley Acquisition Corp valuing the combined business at $638 million, with the combined company expected to list as CUAS.
IPO
Michael Klein's 13th SPAC Prices Upsized $360M IPO
IPO$360M SPAC IPO
Michael Klein's 13th SPAC Prices Upsized $360M IPO
Churchill Capital Corp XIII, Michael Klein's thirteenth blank-check company, priced an upsized $360 million IPO and began trading on Nasdaq as XIIIU, continuing a prolific run of serial SPAC issuance.
IPO
Unitree Sets Shanghai IPO Subscription Dates
IPO~$618M target
Unitree Sets Shanghai IPO Subscription Dates
Chinese humanoid maker Unitree Robotics set book-building for August 5 and public subscription for August 10 on its Shanghai STAR Market IPO, targeting roughly $618 million at a $6.2 billion base valuation.
IPO
Apnimed Prices Upsized IPO at $16, Raises $192M
IPO$192M IPO
Apnimed Prices Upsized IPO at $16, Raises $192M
Apnimed priced an upsized IPO at $16 per share, raising $192 million ahead of its Nasdaq debut under ticker APMD, betting on the first potential FDA-approved pill for obstructive sleep apnea.
IPO
Michael Klein's Churchill Capital XIII Prices $360M IPO
IPO$360M IPO
Michael Klein's Churchill Capital XIII Prices $360M IPO
Serial SPAC sponsor Michael Klein priced Churchill Capital Corp XIII's upsized IPO at $360 million, his latest blank-check vehicle as the SPAC market shows fresh signs of life in 2026.
IPO
Why 2026's IPO Debuts Are Splitting Into Two Tiers
IPO
Why 2026's IPO Debuts Are Splitting Into Two Tiers
This week's IPO calendar is splitting cleanly into two tiers -- AI-adjacent and clinical-stage biotech names popping double digits, while established consumer and franchise brands price cleanly but open flat or down, a divergence worth watching as the 2026 IPO window matures.
IPO
Reformation Debuts on NYSE, Raises $210.9M
IPO$210.9M raised
Reformation Debuts on NYSE, Raises $210.9M
Sustainable womenswear brand Reformation priced its IPO at $15 a share, raising $210.9 million and debuting on the NYSE at a roughly $886 million market value backed by private equity firm Permira.
IPO
Reformation Opens Flat in $211M NYSE Debut
IPO$886M valuation
Reformation Opens Flat in $211M NYSE Debut
Permira-backed sustainable fashion retailer Reformation raised $210.9 million in its NYSE debut, pricing at the bottom of its range and opening flat at $15 for an $886 million market value, well below its initial $1 billion target.
IPO
Jersey Mike's Falls Below IPO Price in NYSE Debut
IPO$7.3B valuation
Jersey Mike's Falls Below IPO Price in NYSE Debut
Jersey Mike's shares opened as much as 9% below their $23 IPO price on the NYSE Thursday before partially recovering, after the Blackstone-backed sandwich chain raised roughly $1 billion valuing the company at $7.3 billion.
IPO
Reformation Opens Flat, Valued at $886M in NYSE Debut
IPO$886M valuation
Reformation Opens Flat, Valued at $886M in NYSE Debut
Reformation opened flat at its $15 IPO price in its NYSE debut Thursday, valuing the Permira-backed sustainable fashion brand at $886.1 million after it raised $210.9 million pricing at the bottom of its range.
IPO
Jersey Mike's Raises $1B in Blackstone-Backed NYSE Debut
IPO$1B IPO
Jersey Mike's Raises $1B in Blackstone-Backed NYSE Debut
Jersey Mike's began trading on the NYSE under ticker JMKE after pricing its IPO at $23 a share, raising roughly $1 billion and valuing the sandwich chain at $7.3 billion, though shares opened below the IPO price as Blackstone retains majority voting control.
IPO
Neocloud Nscale Preps Investor Pitch for Multibillion IPO
IPOMultibillion IPO target
Neocloud Nscale Preps Investor Pitch for Multibillion IPO
AI neocloud Nscale is getting ready to pitch investors on a multibillion-dollar IPO, having hired Goldman Sachs and JPMorgan after raising $2 billion at a $14.6 billion valuation earlier this year.
IPO
Laser Photonics Files Fresh S-1 for Warrant Share Registration
IPO11.8M shares registered
Laser Photonics Files Fresh S-1 for Warrant Share Registration
Laser Photonics filed a new S-1 covering nearly 11.8 million warrant-linked shares for resale, the latest in a series of 2026 filings as the small-cap laser-cleaning maker manages its capital structure.
IPO
Zepto Pauses IPO, Raises Pre-IPO Round Below Peak Value
IPO$4.5B valuation
Zepto Pauses IPO, Raises Pre-IPO Round Below Peak Value
Indian quick-commerce major Zepto postponed its planned IPO and will instead raise roughly $115 million in a pre-IPO round at a $4.5 billion valuation, down from the $7 billion it commanded in October 2025.
IPO
Zhongji Innolight Slides on Its $6.8B Hong Kong Debut
IPO$6.8B raised
Zhongji Innolight Slides on Its $6.8B Hong Kong Debut
Zhongji Innolight, the world's top optical-interconnect supplier, raised $6.8 billion in Hong Kong's biggest listing in seven years, but shares fell as much as 5% on debut as the global AI-stock selloff overshadowed the offering.
IPO
Why This Week's IPO Pricings Signal a Real Reopening
IPO
Why This Week's IPO Pricings Signal a Real Reopening
Three unrelated IPOs -- biotech, consumer apparel, and food-tech -- all moved through the pipeline in the same 48 hours, and the mix, not the size, is what shows the 2026 IPO window has genuinely reopened beyond AI mega-caps.
IPO
OpenAI's $1T IPO Ambition Faces Timing Test as Anthropic Gains
IPO
OpenAI's $1T IPO Ambition Faces Timing Test as Anthropic Gains
OpenAI's push for a $1 trillion IPO valuation faces a fresh timing test as Anthropic, still targeting an October Nasdaq listing, gains ground with a cleaner profitability story and a higher private-market valuation.
IPO
Reformation Prices IPO to Raise Up to $225M
IPO$225M IPO
Reformation Prices IPO to Raise Up to $225M
Sustainable fashion brand Reformation priced its IPO at 14.06 million shares in a $15-17 range, targeting roughly $225 million at the midpoint ahead of its Nasdaq debut this week.
IPO
Exascale Labs Clears Shareholder Vote for Nasdaq Listing
IPOSPAC merger
Exascale Labs Clears Shareholder Vote for Nasdaq Listing
AI infrastructure provider Exascale Labs cleared shareholder approval for its SPAC merger with D. Boral ARC Acquisition, paving the way to begin trading on Nasdaq under the ticker XLAB.
IPO
Why the 2026 IPO Window Is Splitting in Two
IPO
Why the 2026 IPO Window Is Splitting in Two
2026's IPO market is really two separate markets moving in opposite directions at once: trillion-dollar AI-infrastructure names commanding record multiples, and everything else -- from Jersey Mike's to micro-cap S-1 filers -- pricing on old-fashioned fundamentals.
IPO
Goldman-Backed Attovia Sets Terms for $200M Nasdaq IPO
IPO$200M target IPO
Goldman-Backed Attovia Sets Terms for $200M Nasdaq IPO
Attovia Therapeutics set terms for a Nasdaq IPO, offering 12.5 million shares at $15-17 to raise up to $212.5 million, advancing its Phase 1 itch and eczema drug candidates toward a public listing under ticker ATTO.
IPO
The Case For Calling 2026 the Mega-IPO Era
IPO
The Case For Calling 2026 the Mega-IPO Era
IPO pops are nearing 10-year highs and tech is leading the way, with $34.2 billion raised through May -- up 163.9% year-over-year -- setting up 2026 as the strongest new-issue market in a decade even before SpaceX and CXMT's blockbuster debuts.
IPO
Jersey Mike's Prices IPO Tonight at Up to $7.9B Valuation
IPOup to $1.09B
Jersey Mike's Prices IPO Tonight at Up to $7.9B Valuation
Blackstone-backed Jersey Mike's Subs prices its IPO Wednesday night at a targeted $21-$25 a share, valuing the 70-year-old sandwich chain at up to $7.9 billion ahead of its Thursday debut on the NYSE under ticker JMKE.
IPO
Why Anthropic's October IPO Math Keeps Getting Bigger
IPO
Why Anthropic's October IPO Math Keeps Getting Bigger
Anthropic's confidential S-1 targets an October listing off a $965 billion private valuation, but secondary-market trades already imply closer to $1.2 trillion -- a gap the roadshow will have to close one way or the other.
IPO
Goldman-Backed Attovia Seeks $212.5M in Biotech IPO
IPO$212.5M IPO
Goldman-Backed Attovia Seeks $212.5M in Biotech IPO
Attovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.
IPO
This Week's New S-1 Filers: A Mixed IPO Signal
IPO
This Week's New S-1 Filers: A Mixed IPO Signal
Seven operating companies filed fresh S-1 registration statements with the SEC this week, a reminder that beneath the SpaceX- and Anthropic-scale mega-IPO headlines, a steady stream of smaller and micro-cap issuers keeps testing the public markets.
IPO
TSMC Restarts Japan Plant After Deadly Quake
IPO
TSMC Restarts Japan Plant After Deadly Quake
TSMC began gradually restoring operations at its Kumamoto, Japan chip plant after a 7.1-magnitude earthquake killed at least 13 people and forced a temporary employee evacuation, with the facility's core structures confirmed undamaged.
IPO
What SpaceX's Whipsaw Means For The Next Mega-IPO
IPO
What SpaceX's Whipsaw Means For The Next Mega-IPO
SpaceX's $1.2 trillion Tuesday swing is a live pricing lesson for Anthropic and OpenAI, both moving toward IPOs of their own at valuations near $965 billion and $852 billion, respectively.
IPO
Why Half Of 2026's IPO Class Trades Underwater
IPO~50% underwater
Why Half Of 2026's IPO Class Trades Underwater
203 companies have gone public on the NYSE or Nasdaq in 2026, but roughly half now trade below their offering price -- and Tuesday's SpaceX whipsaw shows exactly why scarcity-driven IPO pops keep failing to hold.
IPO
GrubMarket Files Confidential IPO at $4.5B Valuation
IPO$4.5B valuation
GrubMarket Files Confidential IPO at $4.5B Valuation
AI-powered food supply chain company GrubMarket confidentially filed for a US IPO, months after reaching a $4.5 billion valuation in a $50 million February Series H round.
IPO
SpaceX Shares Whipsaw, Briefly Erase $1.2 Trillion
IPO~$1.2T erased
SpaceX Shares Whipsaw, Briefly Erase $1.2 Trillion
SpaceX stock briefly fell more than 20% below its June IPO price on Tuesday, wiping out roughly $1.2 trillion in paper value before paring losses, as the thin public float that fueled its post-IPO pop now works in reverse.
IPO
Apple Crosses $5 Trillion Market Cap
IPO
Apple Crosses $5 Trillion Market Cap
Apple briefly topped a $5 trillion market capitalization for the first time Tuesday, becoming only the second company ever to hit the mark after Nvidia reached it in October 2025, less than a year after Apple itself first crossed $4 trillion.
IPO
Why The $2.1 Trillion IPO Pipeline Is Bigger Than It Looks
IPO
Why The $2.1 Trillion IPO Pipeline Is Bigger Than It Looks
Forge's tech IPO pipeline hit a cumulative $2.1 trillion in valuation this month, but Anthropic's confidential filing at a $965B mark and Jersey Mike's return to public markets show how differently that number will actually convert.
IPO
Catalyst Acquisition Corp Prices $200M SPAC for Gaming
IPO$200M IPO
Catalyst Acquisition Corp Prices $200M SPAC for Gaming
Catalyst Acquisition Corp priced a $200 million IPO on Nasdaq, launching a SPAC targeting traditional and digital media companies including video games, mobile gaming, publishers and studios.
IPO
SpaceX Stock Buys By Lawmakers Draw Conflict Scrutiny
IPO
SpaceX Stock Buys By Lawmakers Draw Conflict Scrutiny
Members of Congress with oversight of NASA and defense contracting have disclosed personal purchases of SpaceX stock since its IPO, raising fresh conflict-of-interest concerns just as lawmakers weigh new space and satellite legislation.
IPO
Value Add Pulse Analysis: The IPO Hype Cycle Returns
IPO49% underwater
Value Add Pulse Analysis: The IPO Hype Cycle Returns
203 companies have gone public on the NYSE or Nasdaq in 2026, but roughly 49% now trade below their IPO price, exposing a widening gap between opening-day demand and durable public-market performance.
IPO
Market Technology Acquisition Corp Closes $205M IPO
IPO$205M IPO
Market Technology Acquisition Corp Closes $205M IPO
Market Technology Acquisition Corp closed its $205 million IPO, with units trading on Nasdaq under 'MTAKU' since July 24, targeting acquisitions in licensed US equities and options clearing infrastructure.
IPO
China's CXMT Triples To $540B, Erasing Chip Rivals' Gains
IPO~$540B Market Cap
China's CXMT Triples To $540B, Erasing Chip Rivals' Gains
ChangXin Memory Technologies surged more than 500% on its Shanghai STAR Market debut to roughly $540 billion, sending SanDisk down 12%, Micron down 5% and SK Hynix down 6-8% in the same session.
IPO
AIxCrypto Holdings Files Follow-On Public Offering
IPO
AIxCrypto Holdings Files Follow-On Public Offering
AIxCrypto Holdings, the Nasdaq-listed company that pivoted from biopharma to AI and blockchain infrastructure, filed a new S-1 for a follow-on public offering, continuing a transformation that began with a November 2025 rebrand.
IPO
Silver Miner Sinda Files Follow-On Offering After IPO Pop
IPO~$213M IPO
Silver Miner Sinda Files Follow-On Offering After IPO Pop
Sinda Ltd, the silver exploration company that raised $213 million in its June NYSE debut, filed an additional registration statement on July 28 to support further securities offerings.
IPO
The IPO Trend Nobody's Advertising: Debt, Then a Dividend
IPO
The IPO Trend Nobody's Advertising: Debt, Then a Dividend
A Value Add Pulse analysis finds a quiet pattern across 2026's consumer and infrastructure IPOs: companies borrowing tens of millions right before filing, or steering the bulk of proceeds to debt and existing holders, rather than new growth capital.
IPO
Why 2026's IPO Market Already Beat Goldman's Bet
IPO$160B IPO Forecast
Why 2026's IPO Market Already Beat Goldman's Bet
A Value Add Pulse analysis of 2026's IPO market finds proceeds already tracking well ahead of Goldman Sachs's February forecast of $160 billion for the full year, driven by a handful of enormous AI-adjacent listings.
IPO
SEC S-1 Wave: Seven Companies File To Go Public
IPO7 filings
SEC S-1 Wave: Seven Companies File To Go Public
Seven companies filed S-1 registration statements with the SEC between July 24 and July 27, spanning blank-check SPACs, real estate and an AI intelligence platform, underscoring how active the public-offering pipeline remains even outside marquee mega-deals.
IPO
SPAC Filing Activity Ticks Up With Fresh S-1/As
IPO
SPAC Filing Activity Ticks Up With Fresh S-1/As
Multiple blank-check companies filed amended S-1/A registration statements this week, including Dune Acquisition Corp III and BOA Acquisition Corp. II, signaling continued SPAC-market activity even as most 2026 IPO attention centers on operating-company mega-deals.
IPO
2026's IPO Window Is Open, But Pricing Is Cut
IPO
2026's IPO Window Is Open, But Pricing Is Cut
Nearly every major consumer and industrial IPO this cycle has priced well below the valuation chatter that preceded it, despite a record first half for new listings.
IPO
Direct Listings Make a Quiet Comeback in 2026
IPO
Direct Listings Make a Quiet Comeback in 2026
Ionic Digital's no-capital-raised direct listing offers a lower-friction alternative to traditional underwritten IPOs for companies that need liquidity, not new cash.
IPO
Memory Stocks Slide As CXMT's IPO Rattles Market
IPO
Memory Stocks Slide As CXMT's IPO Rattles Market
Micron, SanDisk and SK Hynix shares all fell after CXMT's explosive Shanghai IPO debut intensified fears of a looming DRAM supply glut and price war.
IPO
Karman Line Acquisition Files SPAC IPO For Space Deals
IPO20M units
Karman Line Acquisition Files SPAC IPO For Space Deals
Karman Line Acquisition Corp filed an S-1 for a blank-check IPO targeting 20 million units, aiming to merge with a space infrastructure, aerospace or defense company -- the latest SPAC chasing the sector's post-Karman Holdings enthusiasm.
IPO
China's CXMT Soars 470% in Record $8.6B Shanghai IPO
IPO~$8.6B raised
China's CXMT Soars 470% in Record $8.6B Shanghai IPO
ChangXin Memory Technologies debuted on Shanghai's STAR Market Monday, raising roughly $8.6 billion in the largest mainland semiconductor offering on record, before shares surged as much as 531% to make CXMT China's most valuable listed company.
IPO
Angola Raises $321M In Nation's Biggest-Ever IPO
IPO$321M IPO
Angola Raises $321M In Nation's Biggest-Ever IPO
Angola raised $321 million by selling a 15% stake in state wireless carrier Unitel, the country's largest IPO ever and a flagship test of its post-dos Santos privatization program.
IPO
Apnimed Launches $150M IPO for Sleep Apnea Pill
IPO$150M-$160M IPO
Apnimed Launches $150M IPO for Sleep Apnea Pill
Apnimed launched a $150-160 million IPO for a pill that could become the first FDA-approved treatment for obstructive sleep apnea.
IPO
Apnimed Launches $150M IPO For First Sleep Apnea Pill
IPOup to $150M IPO
Apnimed Launches $150M IPO For First Sleep Apnea Pill
Shionogi-backed Apnimed launched a $150 million IPO for its once-daily obstructive sleep apnea pill AD109, targeting a Thursday pricing ahead of a Friday NASDAQ debut.
IPO
Ionic Digital's Direct Listing Debuts on Nasdaq
IPO$2.4B Implied Value
Ionic Digital's Direct Listing Debuts on Nasdaq
Ionic Digital, built from Celsius Mining's bankruptcy, is completing a Nasdaq direct listing as an AI and high-performance-computing infrastructure company.
IPO
Jersey Mike's Set To Price $8B IPO This Week
IPOUp to $1.09B IPO
Jersey Mike's Set To Price $8B IPO This Week
Blackstone-backed sandwich chain Jersey Mike's is set to price its IPO this week at a targeted valuation near $8 billion, the largest US consumer IPO of 2026 in the sector's weakest listing year in a decade.
IPO
SpaceX Stock Sinks Toward Record Insider Unlock
IPO$116B Insider Unlock
SpaceX Stock Sinks Toward Record Insider Unlock
SpaceX shares are trading roughly 42% below their post-IPO peak heading into the company's first public earnings report and a record insider share unlock.
IPO
CXMT Rockets 466% in STAR Market Trading Debut
IPO$8.6B Raised, +471%
CXMT Rockets 466% in STAR Market Trading Debut
Chinese memory maker CXMT surged as much as 471% in its Shanghai STAR Market trading debut, instantly becoming mainland China's most valuable listed company.
IPO
Shein's IPO Prospectus Reveals Slowing Growth
IPO$40B-$50B Target
Shein's IPO Prospectus Reveals Slowing Growth
Shein's Hong Kong IPO prospectus disclosed slowing revenue growth and a swing to a quarterly loss, complicating its push for a $40-50 billion valuation.
IPO
Zhongji Innolight Seeks $7B Hong Kong Mega IPO
IPO$8.1B Hong Kong IPO
Zhongji Innolight Seeks $7B Hong Kong Mega IPO
Chinese optical networking supplier Zhongji Innolight is completing an up to $8 billion Hong Kong IPO, the city's largest listing in seven years, riding surging demand for AI data center optics.
IPO
Why 2026's Tech IPO Pipeline Keeps Accelerating
IPO$129.3B H1 2026
Why 2026's Tech IPO Pipeline Keeps Accelerating
New-listing proceeds and first-day returns both hit multi-year highs in the first half of 2026, evidence the reopened IPO window is broadening rather than fading.
IPO
Plaid, Verkada Quietly Line Up Banks for IPOs
IPO
Plaid, Verkada Quietly Line Up Banks for IPOs
Two well-capitalized infrastructure unicorns are separately testing the IPO waters, suggesting the reopened window extends beyond consumer brands and SpaceX-scale mega-deals.
IPO
Crypto's IPO Hopefuls Face a Steep Valuation Reset
IPO
Crypto's IPO Hopefuls Face a Steep Valuation Reset
Crypto prime broker FalconX and Blockchain.com have both filed confidentially for U.S. IPOs, but analysts expect valuations far below their 2022 peaks in today's cautious market.
IPO
Reformation Prices Alongside Jersey Mike's This Week
IPO$293M IPO
Reformation Prices Alongside Jersey Mike's This Week
Reformation is pricing its NYSE debut the same night as Jersey Mike's, giving investors a rare back-to-back read on consumer-brand IPO appetite.
IPO
Why AI Capex Is Now the IPO Market's Biggest Swing Factor
IPO
Why AI Capex Is Now the IPO Market's Biggest Swing Factor
Value Add Pulse analysis: with Google posting negative free cash flow and Tesla's capex miss triggering a global selloff, AI capital spending discipline has become the single largest variable public investors price into any AI-adjacent IPO.
IPO
Jersey Mike's Roadshow Targets Up to $1.09B Raise
IPO$1.09B IPO
Jersey Mike's Roadshow Targets Up to $1.09B Raise
Jersey Mike's is mid-roadshow on its NYSE listing at a $21-$25 per-share range, well below earlier chatter, ahead of a targeted July 30 debut under ticker JMKE.
IPO
The Case For a Chinese AI IPO Wave Riding CXMT's Momentum
IPO
The Case For a Chinese AI IPO Wave Riding CXMT's Momentum
Value Add Pulse analysis: CXMT's $8.6 billion Shanghai debut and the Moonshot/DeepSeek open-model rush suggest Chinese AI and semiconductor companies are finding a public-market window U.S. peers currently lack.
IPO
Fusion Pioneer GFUZ Cools Off After Nasdaq Debut
IPO
Fusion Pioneer GFUZ Cools Off After Nasdaq Debut
The first pure-play fusion company to trade on a major exchange has cooled from its debut-day highs as investors settle into valuing pre-revenue fusion technology.
IPO
Why 2026's IPO Pipeline Keeps Getting Deferred, Not Canceled
IPO
Why 2026's IPO Pipeline Keeps Getting Deferred, Not Canceled
Value Add Pulse analysis: the $2.1 trillion tech IPO pipeline Forge has tracked keeps sliding to the right as capex-driven selloffs and quality-gap concerns push companies to wait rather than withdraw.
IPO
Scribe Therapeutics Prices Upsized IPO With Sanofi Backing
IPO$128.7M Raised
Scribe Therapeutics Prices Upsized IPO With Sanofi Backing
Gene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.
IPO
China's CXMT Sparks Cash-Drain Fears Ahead of $8.6B IPO
IPO$8.6B IPO
China's CXMT Sparks Cash-Drain Fears Ahead of $8.6B IPO
CXMT, China's largest memory chipmaker, is set to list July 27 on Shanghai's STAR Market in Asia's biggest IPO of 2026 so far, raising $8.6 billion and stoking fears it could drain cash from Chinese equities.
IPO
Ten S-1 Filings Land in a Week as IPO Plumbing Keeps Running
IPO
Ten S-1 Filings Land in a Week as IPO Plumbing Keeps Running
A wave of at least ten S-1 and S-1/A filings hit the SEC in the week of July 22-24, spanning eyewear, batteries, biotech and identity-verification companies, evidence the IPO pipeline keeps moving even without a headline mega-deal.
IPO
Google Discloses $94.1B SpaceX, $124B Anthropic Stakes
IPO$218B Combined Stakes
Google Discloses $94.1B SpaceX, $124B Anthropic Stakes
Alphabet's Q2 filing revealed a $94.1 billion SpaceX stake and a roughly $124.3 billion Anthropic stake, with nearly $98 billion in combined paper gains helping drive a record $112 billion quarterly profit.
IPO
SpaceX Shares Fall Below Their IPO Price for First Time
IPOBelow $135 IPO Price
SpaceX Shares Fall Below Their IPO Price for First Time
SpaceX shares dropped below their $135 IPO price for the first time since June, down nearly 47% from their post-listing peak, as the largest IPO in history struggles just six weeks after debuting.
IPO
Scribe Therapeutics Soars In Rare Gene-Editing IPO
IPO$128.7M IPO
Scribe Therapeutics Soars In Rare Gene-Editing IPO
Scribe Therapeutics priced an upsized $128.7 million IPO and surged in its Nasdaq debut, a rare early-stage listing for a gene-editing biotech in a market that has favored de-risked, later-stage companies.
IPO
Moonshot Preps IPO Under Cloud of US Theft Accusation
IPO
Moonshot Preps IPO Under Cloud of US Theft Accusation
Moonshot AI is advancing its own IPO preparations even as the White House publicly accuses it of covertly distilling Anthropic's model to build its viral open-weight Kimi K3, a claim Moonshot disputes and researchers say lacks public evidence.
IPO
The IPO Pipeline's Quality Gap Is Widening Fast
IPO
The IPO Pipeline's Quality Gap Is Widening Fast
A $2.1 trillion IPO pipeline and 44.5% average first-day gains sit alongside Avalanche Treasury's 73% crash and underwater energy IPOs, showing 'golden age' framing masks diverging quality.
IPO
China's AI Labs Race Toward A Wave Of IPOs
IPO
China's AI Labs Race Toward A Wave Of IPOs
Moonshot, DeepSeek, MiniMax and Z.ai are all pursuing or completing public listings within months of each other, a compressed wave of Chinese AI IPOs that resets how investors value the entire sector.
IPO
The Energy IPO Boom Has a Below-Issue-Price Problem
IPO
The Energy IPO Boom Has a Below-Issue-Price Problem
Energy-sector IPOs raised a record $12.6 billion in H1 2026 chasing AI power demand, but more than 60% of newly listed names are trading below their issue price -- a gap between capital-raising momentum and aftermarket performance worth watching.
IPO
Reformation Files for NYSE IPO Off 20 Growth Quarters
IPOup to $1B target valuation
Reformation Files for NYSE IPO Off 20 Growth Quarters
Sustainable womenswear brand Reformation filed an amended S-1 for a proposed NYSE listing under ticker REF, off 20 straight quarters of double-digit growth, targeting up to a $1 billion valuation.
IPO
Moonshot, DeepSeek Both Race Toward IPOs After Kimi Shock
IPO
Moonshot, DeepSeek Both Race Toward IPOs After Kimi Shock
Moonshot AI is preparing a Hong Kong listing within six months and DeepSeek is targeting Shanghai's STAR Market by Q2 2027, as China's AI labs race toward public markets after Kimi K3's shock.
IPO
Tech IPO Pipeline Swells to $2.1 Trillion, Forge Says
IPO$2.1T Pipeline
Tech IPO Pipeline Swells to $2.1 Trillion, Forge Says
Forge's tech IPO pipeline tracker now carries a cumulative $2.1 trillion in valuation across companies with announced plans or filings -- even as SpaceX and Csquare both trade below or near their debut levels.
IPO
Barclays Declares a 'Golden Age' for Tech IPOs
IPO
Barclays Declares a 'Golden Age' for Tech IPOs
Barclays' head of TMT equity capital markets called the current market a 'golden age' for tech IPOs, citing overlapping boom cycles across AI, power infrastructure, robotics, defense tech and space with capacity to absorb far more listings.
IPO
Three New SPACs File to Raise $500M+ in a Single Week
IPO$500M+ combined
Three New SPACs File to Raise $500M+ in a Single Week
Pinnacle Acquisition, NorthStrive Acquisition I and Market Technology Acquisition Corp all filed SPAC registrations this week targeting $500 million-plus across finance, manufacturing and clearing infrastructure.
IPO
TECfusions to Go Public in $4B SPAC Deal for AI Data Centers
IPO$4B SPAC merger
TECfusions to Go Public in $4B SPAC Deal for AI Data Centers
TECfusions, which converts former industrial sites into AI-ready data centers, agreed to go public via a $4 billion SPAC merger with Apex Treasury Corp, part of a wave of energy-and-infrastructure listings chasing AI power demand.
IPO
Shein Wins Hong Kong Listing Nod, Eyes Up to $50B IPO
IPO$40B-$50B Target
Shein Wins Hong Kong Listing Nod, Eyes Up to $50B IPO
Shein secured approval from Hong Kong's listing committee for an IPO after already winning Chinese regulatory clearance, setting up a high-stakes debut as soon as September at a valuation of up to $50 billion.
IPO
After SpaceX's $2T Debut, Investors Chase the 'Magnificent Three'
IPO>$200B combined liquidity
After SpaceX's $2T Debut, Investors Chase the 'Magnificent Three'
SpaceX's mega-IPO pushed its valuation above $2.7 trillion and record retail trading volume, fueling investor appetite for Anthropic and OpenAI's prospective listings -- a trio investors are now calling the 'Magnificent Three.'
IPO
Starfighters Space Amends IPO Filing as Space Sector Heats Up
IPO~$17.5M PIPE raise
Starfighters Space Amends IPO Filing as Space Sector Heats Up
Starfighters Space, a Florida aerospace testing company, filed an amended S-1/A for its Nasdaq listing under ticker FJET, joining smaller space names riding SpaceX's IPO halo effect.
IPO
After SpaceX's $2T Debut, Investors Eye Anthropic and OpenAI
IPO
After SpaceX's $2T Debut, Investors Eye Anthropic and OpenAI
With SpaceX trading as a roughly $2 trillion public company, market strategists are now mapping out how retail and institutional investors could get exposure to the next trillion-dollar AI IPO candidates, Anthropic and OpenAI.
IPO
China's CXMT Prices Record $8.5B Shanghai Chip IPO
IPO~$8.5B raised
China's CXMT Prices Record $8.5B Shanghai Chip IPO
China's DRAM champion ChangXin Memory Technologies priced an $8.5 billion IPO on Shanghai's STAR Market, implying an $85 billion valuation and becoming the venue's second-largest listing ever, with trading set to begin July 27.
IPO
Avalanche Treasury Warns It May Not Survive After 73% Crash
IPO-73% since debut
Avalanche Treasury Warns It May Not Survive After 73% Crash
Avalanche Treasury Corp, a Nasdaq vehicle that accumulates AVAX on its balance sheet, has crashed 73% since its June debut and warned in a filing that it may not survive.
IPO
US Biotech Axiom Chooses Hong Kong Listing Over Wall Street
IPO
US Biotech Axiom Chooses Hong Kong Listing Over Wall Street
US biotech firm Axiom AIOSciences is listing in Hong Kong before pursuing a US listing, a reversal of the usual playbook that reflects how competitive Asian capital markets have become for biotech and AI-adjacent listings.
IPO
Goldman Sachs Launches Private Markets Platform for Rich Investors
IPO
Goldman Sachs Launches Private Markets Platform for Rich Investors
Goldman Sachs created a private markets platform to give wealthy investors exposure to pre-IPO companies like the next SpaceX or Stripe, formalizing Wall Street's push into late-stage private deals.
IPO
Super Micro Surges 15% on New AI Server Orders Tied to SpaceX
IPO+15% on $60B orders
Super Micro Surges 15% on New AI Server Orders Tied to SpaceX
Super Micro shares jumped 15% after disclosing new AI server orders topped $60 billion and gross margins would nearly double, with CEO Charles Liang citing a new gigawatt data center build with SpaceX and xAI.
IPO
Super Micro Surges 15% on New Order Tied to SpaceX
IPO
Super Micro Surges 15% on New Order Tied to SpaceX
Super Micro shares jumped 15% after disclosing a new order and improved margin outlook tied to a SpaceX-linked announcement, showing how tightly server supply chains are tethered to a few mega-cap customers.
IPO
SpaceX Sets Earnings Date That Triggers First Big Share Unlock
IPO
SpaceX Sets Earnings Date That Triggers First Big Share Unlock
SpaceX snapped a seven-day losing streak and set an earnings date that coincides with its first major post-IPO share-lockup expiration, a milestone that historically pressures newly public stocks as insiders become free to sell.
IPO
OpenAI Adds Two Bank CEOs to Board Ahead of IPO
IPO$852B Reported Valuation
OpenAI Adds Two Bank CEOs to Board Ahead of IPO
OpenAI named Nubank CEO David Velez and BNY CEO Robin Vince to its board, with Vince chairing the audit committee, as the company advances toward an IPO off a reported $852 billion valuation.
IPO
SpaceX's First Earnings Date Triggers a Massive Share Unlock
IPOUp to 911.5M shares
SpaceX's First Earnings Date Triggers a Massive Share Unlock
SpaceX set August 4 for its first quarterly earnings report as a public company, triggering an initial share-unlock window that could release up to 20% of restricted insider holdings starting August 6.
IPO
Ionic Digital Pivots From Bitcoin Mining to List on Nasdaq
IPO$2.0B implied valuation
Ionic Digital Pivots From Bitcoin Mining to List on Nasdaq
Ionic Digital, born from Celsius Mining's bankruptcy, will direct list on Nasdaq July 28 at a potential $2 billion valuation, repositioning from bitcoin mining to AI and high-performance-computing infrastructure.
IPO
Goldman Sachs Builds Private Markets Platform to Chase the Next SpaceX
IPO
Goldman Sachs Builds Private Markets Platform to Chase the Next SpaceX
Goldman Sachs launched a new alternative investments platform giving wealthy clients direct stakes in individual private companies rather than broad funds, as investors clamor for pre-IPO access to names like SpaceX and Stripe.
IPO
OpenAI Adds Nubank, BNY CEOs to Board Ahead of Potential IPO
IPO
OpenAI Adds Nubank, BNY CEOs to Board Ahead of Potential IPO
OpenAI appointed Nubank CEO David Vélez and BNY CEO Robin Vince to its board, adding deep public-markets and financial-services experience as the company builds governance infrastructure suited to a future as a public company.
IPO
B&R Technology Merger Prices $325M SPAC for AI Bets
IPO$325M SPAC IPO
B&R Technology Merger Prices $325M SPAC for AI Bets
B&R Technology Merger priced a $325 million SPAC IPO on Nasdaq, one of the largest blank-check offerings this year targeting technology companies with AI tailwinds.
IPO
Anthropic's IPO Roadshow Begins as Bankers Line Up Investors
IPO$965B target valuation
Anthropic's IPO Roadshow Begins as Bankers Line Up Investors
Banks leading Anthropic's IPO have begun scheduling investor meetings, the opening stage of a roadshow that typically precedes a listing by four to eight weeks, keeping the company on track for a possible October Nasdaq debut.
IPO
Hyperliquid Strategies Amends IPO Filing as Crypto Treasury Race Heats Up
IPO
Hyperliquid Strategies Amends IPO Filing as Crypto Treasury Race Heats Up
Hyperliquid Strategies filed an amended S-1, continuing its push toward a public listing as a crypto treasury company built around the Hyperliquid exchange token, joining a wave of digital-asset treasury vehicles racing to go public.
IPO
Six IPOs Priced Today. Here's What the Window Really Looks Like
IPO6 pricings in one day
Six IPOs Priced Today. Here's What the Window Really Looks Like
Six companies priced IPOs on July 20 alone -- from Jersey Mike's $7.9B consumer offering to Csquare's data-center debut -- the clearest evidence yet that 2026's IPO reopening extends well past AI-branded listings.
IPO
General Fusion's Debut Sets a Precedent for Hard-Tech IPOs
IPO$150M starting cash
General Fusion's Debut Sets a Precedent for Hard-Tech IPOs
General Fusion became the first publicly traded pure-play fusion energy company on July 13, a milestone landing as private fusion funding surges to $4.5 billion over the past year.
IPO
Grayscale Files S-1 for a Worldcoin ETF
IPO
Grayscale Files S-1 for a Worldcoin ETF
Grayscale filed an S-1 for a Worldcoin ETF, extending the crypto ETF wave into a token tied to Sam Altman's iris-scanning identity project, at a moment when crypto regulation is a live political flashpoint.
IPO
DeepSeek's STAR Market Path: A $71B Test for China's AI IPOs
IPO$71B pre-money talks
DeepSeek's STAR Market Path: A $71B Test for China's AI IPOs
DeepSeek is in talks to raise at a $71 billion pre-money valuation ahead of a targeted Shanghai STAR Market listing, weeks after its first-ever outside funding round -- a test case for how China's AI IPO pipeline prices against US frontier labs.
IPO
Anthropic's October Test: Can It Avoid OpenAI's Delay?
IPO$965B private valuation
Anthropic's October Test: Can It Avoid OpenAI's Delay?
Anthropic is targeting an October 2026 Nasdaq listing at a $965 billion valuation with Goldman Sachs and Morgan Stanley leading -- racing to go public first now that OpenAI has pushed its own IPO target from fall 2026 to 2027.
IPO
SpaceX Is Down 39% From Its Post-IPO High. Now What?
IPO-39% from post-IPO high
SpaceX Is Down 39% From Its Post-IPO High. Now What?
SpaceX went public at a $1.77 trillion valuation in the largest IPO ever, peaked above $225, and now trades close to 39% below that high near its original $135 offering price.
IPO
Jersey Mike's Launches IPO Roadshow at Up to $7.9B
IPOUp to $1.09B raise
Jersey Mike's Launches IPO Roadshow at Up to $7.9B
Jersey Mike's kicked off its IPO roadshow targeting up to a $7.94 billion valuation, offering 43.5 million shares at $21-25 apiece to raise as much as $1.09 billion in one of the largest consumer-brand listings of the year.
IPO
Why 2026's IPO Class Is Splitting Into Two Tapes
IPO
Why 2026's IPO Class Is Splitting Into Two Tapes
Mega-cap AI-infrastructure listings are trading like risk assets -- SpaceX down 42% from its post-IPO peak, Csquare pricing below range -- while a wave of micro-cap biotech S-1s from NuvOx and Valion Bio moves ahead on its own clinical calendar, unaffected.
IPO
China's Moonshot Plans Hong Kong IPO Within Six Months After Kimi K3 Shock
IPO$30B+ target valuation
China's Moonshot Plans Hong Kong IPO Within Six Months After Kimi K3 Shock
Moonshot AI has told investors it plans to list in Hong Kong within six months at a valuation above $30 billion, accelerating its IPO timeline after Kimi K3 -- a 2.8-trillion-parameter open-weight model -- matched frontier US labs and briefly wiped hundreds.
IPO
CXMT's $8.6B Shanghai IPO Draws 500x Institutional Demand
IPO$8.6B IPO / ~$87B cap
CXMT's $8.6B Shanghai IPO Draws 500x Institutional Demand
China's largest DRAM maker CXMT priced an $8.6 billion Shanghai STAR Market IPO -- Asia's biggest listing of 2026 -- with institutional demand of roughly 500 times the shares on offer, though oversubscription ran lower than recent Chinese tech IPOs amid a.
IPO
Databricks' $188B Mark Tests the Private-Public Gap
IPO$188B private mark
Databricks' $188B Mark Tests the Private-Public Gap
Value Add Pulse analysis: Databricks tripled its valuation to $188B in 19 months without a single public trading day, making it the clearest test of whether private AI marks survive contact with public markets.
IPO
What SpaceX's 105x Multiple Means for the IPO Pipeline
IPO~105x implied multiple
What SpaceX's 105x Multiple Means for the IPO Pipeline
Value Add Pulse analysis: SpaceX's median analyst target implies a 105x revenue multiple even after a 42% post-IPO decline, a comp every AI-adjacent IPO hopeful will now be measured against.
IPO
Wall Street's $800 SpaceX Target Meets a 42% Crash
IPO$225 median target
Wall Street's $800 SpaceX Target Meets a 42% Crash
Eighteen banks issued SpaceX targets as high as $800, but the stock has fallen ~42% from its post-IPO peak and now trades near its $135 offer price, a gap that looks like herd behavior, not analysis.
IPO
Valion Bio Files S-1, Joins July's Biotech IPO Wave
IPO
Valion Bio Files S-1, Joins July's Biotech IPO Wave
Valion Bio filed a preliminary prospectus for common stock, pre-funded warrants and common warrants, the latest in a cluster of biotech S-1 filings reaching the SEC in mid-July even as tech-sector IPO sentiment cooled.
IPO
NuvOx Therapeutics Files S-1 for Nasdaq Listing
IPO
NuvOx Therapeutics Files S-1 for Nasdaq Listing
Tucson-based NuvOx Therapeutics filed an S-1 with the SEC, joining a wave of small biopharma companies testing public-market appetite even as broader tech and AI-infrastructure equities had a rough week.
IPO
Apple's Trade-Secrets Suit Threatens OpenAI's IPO
IPOIPO odds: 18.5%
Apple's Trade-Secrets Suit Threatens OpenAI's IPO
Apple's trade-secrets lawsuit against OpenAI, alleging its hardware chief directed former Apple staff to bring 'actual parts' to interviews, has already cut Wall Street's odds of a 2026 OpenAI IPO from roughly 22% to 18.5%.
IPO
Public Markets Are Stress-Testing the AI Infra Trade
IPO
Public Markets Are Stress-Testing the AI Infra Trade
Value Add Pulse analysis: Csquare's soft debut, Standard Nuclear's downsized listing, SpaceX's Starship setback and Alphabet's Gemini-delay selloff landed within 48 hours, showing markets are pricing AI-infra execution risk in real time.
IPO
IPO Party Faces Down Volatility, Sinking SpaceX
IPO
IPO Party Faces Down Volatility, Sinking SpaceX
Newcomer's weekly analysis asks whether 2026's red-hot IPO window can survive SpaceX's post-listing stock collapse and a broader volatility spike, with several AI-adjacent companies still queued to list this year.
IPO
12 New S-1 Filings Show a Micro-Cap Biotech Wave
IPO
12 New S-1 Filings Show a Micro-Cap Biotech Wave
A dozen new SEC S-1 and S-1/A filings this week, dominated by small biotech and biopharma names, show a steady drip of micro-cap public offerings continuing well below the AI-mega-cap headlines dominating the IPO conversation.
IPO
SpaceX Falls Further as Starship Test Flight Aborted
IPO
SpaceX Falls Further as Starship Test Flight Aborted
SpaceX shares fell further in premarket trading after a Starship test flight was aborted when several engines failed to start, adding a fresh operational setback on top of the stock's already-below-issue-price slide.
IPO
Seven Companies File S-1s in a Single Week
IPO
Seven Companies File S-1s in a Single Week
Seven companies spanning biotech, fintech, AI and battery materials filed IPO registration paperwork with the SEC within days of each other, a broad-based cluster that extends the sustained widening of 2026's listing pipeline.
IPO
Brookfield's Csquare Prices Below Range, Opens Down
IPO$3.24B valuation
Brookfield's Csquare Prices Below Range, Opens Down
Brookfield-backed data center provider Csquare priced its IPO at $21 a share, below its marketed range, and opened down about 3% at $20.90, a soft debut that signals investor caution toward new data-center listings despite AI-driven demand.
IPO
The IPO Pipeline Is Quietly Getting Longer
IPO
The IPO Pipeline Is Quietly Getting Longer
Value Add Pulse analysis: the mix of filings landing in mid-July 2026 -- SPAC revival, sustained biotech S-1s, mega-cap AI IPO prep and a wobbling SpaceX debut -- shows a pipeline broadening in kind, not just size.
IPO
Standard Nuclear Debuts on NYSE After 58% IPO Cut
IPO$150M raise, $2.4B cap
Standard Nuclear Debuts on NYSE After 58% IPO Cut
TRISO fuel maker Standard Nuclear began trading on the NYSE under ticker STDN after slashing its IPO size by 58% to $150 million on the eve of pricing, a live early test of how public markets value pre-revenue nuclear-fuel suppliers.
IPO
Brookfield-Backed Csquare Slips in $3.24B NYSE Debut
IPO$1.05B raised
Brookfield-Backed Csquare Slips in $3.24B NYSE Debut
Data-center operator Csquare priced its IPO $2 below range at $21 a share, raising $1.05 billion, and slipped further on its NYSE debut -- a soft landing for the year's newest bet on AI-driven data-center demand.
IPO
SpaceX Stock Slide Costs Musk Trillionaire Status
IPOBelow $135 IPO price
SpaceX Stock Slide Costs Musk Trillionaire Status
SpaceX shares fell below their $135 IPO price for the first time, erasing enough of Elon Musk's paper wealth to end his trillionaire status.
IPO
Standard Nuclear Slashes IPO Size by 58% Ahead of Pricing
IPO$150M raise, ~$2.4B cap
Standard Nuclear Slashes IPO Size by 58% Ahead of Pricing
TRISO fuel maker Standard Nuclear cut its IPO to $150 million from a planned $355.88 million on the eve of pricing, a rare down-sizing that signals soft investor demand even inside the hot nuclear-fuel supply-chain theme.
IPO
SpaceX Shares Slip Below Their $135 IPO Price
IPOBelow $135/share
SpaceX Shares Slip Below Their $135 IPO Price
SpaceX stock traded below its $135 IPO price for the first time, a notable early test for one of the most anticipated public listings in recent market history.
IPO
Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue
IPO
Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue
Jaguar Health and Vogenx both filed S-1 paperwork with the SEC, adding to a biotech IPO queue that's grown steadily through 2026 as public-market appetite for clinical-stage listings recovers.
IPO
SPAC and Fintech S-1 Filings Surge in a Single Day
IPO
SPAC and Fintech S-1 Filings Surge in a Single Day
Banzai International, FreeCast, authID and Churchill Capital Corp XIII all filed IPO or SPAC-related paperwork with the SEC the same day, a notable cluster in an otherwise quiet software-listing environment.
IPO
Anthropic Moves Closer to a Mega-IPO
IPO
Anthropic Moves Closer to a Mega-IPO
Anthropic is moving closer to a public listing, with bankers reportedly lining up investor meetings, a step that would make it one of the largest AI IPOs alongside OpenAI's own expected debut.
IPO
Stripe's Deal Pace Accelerates With Reported $53B PayPal Bet
IPO~$53B reported deal
Stripe's Deal Pace Accelerates With Reported $53B PayPal Bet
Stripe's acquisition pace has accelerated meaningfully, with nothing rivaling its reported interest in a roughly $53 billion PayPal-related deal, a scale of ambition unusual for a still-private fintech giant.
IPO
Standard Nuclear Amends Its NYSE IPO Filing
IPO
Standard Nuclear Amends Its NYSE IPO Filing
Standard Nuclear filed an amended S-1/A refining terms for its planned NYSE listing to fund its small modular reactor buildout, a sign underwriters are finalizing roadshow pricing.
IPO
The SPAC Pipeline Is Quietly Filling Back Up
IPO
The SPAC Pipeline Is Quietly Filling Back Up
Two SPAC vehicles, Crestone Strategic Capital and Material Resource Acquisition Corp, both progressed toward listing this week, a quiet sign the blank-check market is testing itself again.
IPO
Morgan Stanley Amends Ethereum and Solana Trust Filings
IPO
Morgan Stanley Amends Ethereum and Solana Trust Filings
Morgan Stanley filed amended S-1s for both a Morgan Stanley Ethereum Trust and a Morgan Stanley Solana Trust, extending the spot-Bitcoin-ETF playbook to the next tier of large-cap tokens.
IPO
Two New Biotech IPO Filings Land in One Week
IPO2 S-1s, same week
Two New Biotech IPO Filings Land in One Week
Braveheart Bio and Attovia Therapeutics both filed S-1s the same week, adding two names to 2026's biotech IPO pipeline amid the strongest H1 biotech venture funding since 2022.
IPO
Anthropic's $965B Mark Meets the Physical-Infra IPO
IPO$965B valuation, $47B revenue
Anthropic's $965B Mark Meets the Physical-Infra IPO
Anthropic's confidential S-1 and $965 billion valuation sit against a backdrop where this year's actual IPO winners -- SK Hynix, Csquare, Standard Nuclear -- have all been physical infrastructure, not software-first AI labs.
IPO
The Software IPO Drought Behind 2026's Infra Boom
IPOInfra IPOs vs thin software pipeline
The Software IPO Drought Behind 2026's Infra Boom
SK Hynix, Csquare, Standard Nuclear and Meta's $50B Louisiana buildout keep winning capital while pure application-layer software IPOs stay scarce -- a gap that's now wide enough to be the real 2026 IPO story.
IPO
Plaid's IPO Chatter Is a Fintech Market Signal
IPO$8B considered valuation
Plaid's IPO Chatter Is a Fintech Market Signal
Plaid is weighing a US IPO after reaching an $8 billion valuation, still well below its 2021 peak of $13.4 billion, a signal of how selectively fintech valuations are recovering as physical AI infrastructure dominates IPO attention.
IPO
DeepSeek in Talks to Raise $1.5B, Then IPO
IPO$1.5B raise
DeepSeek in Talks to Raise $1.5B, Then IPO
DeepSeek is reportedly in talks to raise $1.5 billion in private funding as a step toward an eventual IPO, following Goldman Sachs naming it a preferred Chinese AI model.
IPO
Quantum Corp Files S-1 for a Fresh Public Listing
IPO
Quantum Corp Files S-1 for a Fresh Public Listing
Legacy data-storage company Quantum Corp filed a new S-1 with the SEC, a notable re-listing move as AI-driven data growth renews demand for storage infrastructure.
IPO
The SPAC Market's Quiet 2026 Comeback
IPO$9.8B Q2 2026
The SPAC Market's Quiet 2026 Comeback
SPACs priced 55 IPOs raising $9.8 billion in Q2 2026 alone, and a fresh wave of merger announcements -- from healthcare to energy to biotech -- shows the vehicle finding real footing again after its 2022-era collapse.
IPO
Biotech's IPO Window: Open, But Only for the Strongest Pipelines
IPO$45M target
Biotech's IPO Window: Open, But Only for the Strongest Pipelines
Tarsier Pharma's ~$45 million NYSE American debut shows biotech's IPO window remains open in 2026 -- but only for companies with genuinely differentiated, late-stage pipelines, not broad speculative interest.
IPO
SK Hynix's Pop Is a Preview of the OpenAI-Anthropic IPO Fight
IPO$2T+ combined
SK Hynix's Pop Is a Preview of the OpenAI-Anthropic IPO Fight
SK Hynix's 13% first-day pop is the freshest data point ahead of a much bigger test: OpenAI and Anthropic are both racing toward IPOs that could value the two labs at a combined $2 trillion or more.
IPO
Chinese Humanoid Robotics Startups Rush Toward IPOs
IPO$2.21B (LimX)
Chinese Humanoid Robotics Startups Rush Toward IPOs
LimX Dynamics and Unitree are rushing toward IPOs as Chinese humanoid-robotics companies treat a public listing as close to mandatory, following LimX's $200 million pre-IPO round at a $2.21 billion valuation.
IPO
Standard Nuclear Files for NYSE IPO to Fund SMR Buildout
IPO$356M target
Standard Nuclear Files for NYSE IPO to Fund SMR Buildout
Standard Nuclear plans to list on the NYSE this week, offering 18.25 million shares at $18-$21 to raise roughly $356 million at a $3.3 billion valuation, funding its small modular reactor buildout.
IPO
Data-Center Operator Csquare Files for $1.25B NYSE IPO
IPO$1.25B target
Data-Center Operator Csquare Files for $1.25B NYSE IPO
Csquare, a data-center operator, is set to list on the NYSE this week offering 50 million shares at $23-$27, targeting roughly $1.25 billion at the midpoint -- one of two infrastructure IPOs headlining this week's calendar.
IPO
SK Hynix Begins Regular Nasdaq Trading as Ticker Flips to SKHY
IPO$26.5B raised
SK Hynix Begins Regular Nasdaq Trading as Ticker Flips to SKHY
SK Hynix's ADRs began trading under their permanent ticker SKHY on Monday, days after the memory-chip giant's $26.5 billion Nasdaq debut -- the largest-ever US listing by a non-American company -- popped 13% on its first day.
IPO
Why 2026's IPO Boom Keeps Rewarding Infrastructure First
IPO
Why 2026's IPO Boom Keeps Rewarding Infrastructure First
Value Add Pulse analysis: the largest, best-received 2026 IPOs and pre-IPO windfalls have overwhelmingly gone to the physical and financial infrastructure underneath AI, not to application-layer companies riding on top of it.
IPO
James Murdoch's SpaceX Bet Nets $7.5 Billion
IPO$7.5B windfall (est.)
James Murdoch's SpaceX Bet Nets $7.5 Billion
James Murdoch's roughly $120 million of pre-IPO SpaceX stock, bought in 2019 and 2020 via Lupa Systems, could now be worth as much as $7.4 billion following SpaceX's public listing, Pitchbook analysis shows.
IPO
Why the 2026 IPO Boom Is About to Broaden Beyond AI
IPO
Why the 2026 IPO Boom Is About to Broaden Beyond AI
US IPO proceeds hit roughly $115.6 billion in H1 2026 on a handful of AI and chip mega-deals, but Fortune reports strategists expect H2 to broaden into manufacturing, defense and energy listings.
IPO
SK Hynix Jumps 13% in Record $26.5B Nasdaq Debut
IPO$26.5B
SK Hynix Jumps 13% in Record $26.5B Nasdaq Debut
SK Hynix's ADRs priced at $149 and closed up nearly 13% on their Nasdaq debut, raising $26.5 billion in the largest first-time U.S. listing by a foreign company on record.
IPO
SK Hynix Raises $26.5B in Largest-Ever Foreign US IPO
IPO$26.5B IPO
SK Hynix Raises $26.5B in Largest-Ever Foreign US IPO
SK Hynix priced 177.9 million ADRs at $149 each to raise $26.5 billion on Nasdaq, topping Alibaba's 2014 debut as the largest US listing ever by a foreign company, and popped 14% at the open.
IPO
Holtec Nuclear Files for Nasdaq IPO to Fund SMR Buildout
IPO
Holtec Nuclear Files for Nasdaq IPO to Fund SMR Buildout
Holtec Nuclear Corp, which owns and is restarting Michigan's 800 MW Palisades plant and leads spent-fuel storage, filed for a Nasdaq listing to fund its SMR-300 small modular reactor rollout.
IPO
Apnimed Files for Nasdaq IPO on First Oral Sleep Apnea Pill
IPO
Apnimed Files for Nasdaq IPO on First Oral Sleep Apnea Pill
Apnimed, a Shionogi-backed clinical-stage biotech, filed for a Nasdaq IPO under ticker APMD as its lead drug candidate Oxnimbi -- the first investigational oral pill for obstructive sleep apnea -- awaits an FDA decision expected in Q1 2027.
IPO
AI Infrastructure Firm Corvex Goes Public via Movano Reverse Merger
IPO
AI Infrastructure Firm Corvex Goes Public via Movano Reverse Merger
AI infrastructure company Corvex is going public through a reverse merger with public shell Movano Inc., with Corvex shareholders projected to own about 94.8% of the combined entity.
IPO
Healthcare Triangle Registers $50M Equity Line With Hudson
IPO
Healthcare Triangle Registers $50M Equity Line With Hudson
Healthcare Triangle filed an S-1 registering 28 million shares for resale by Hudson Global Ventures, giving the Nasdaq-listed healthcare-cloud company access to up to $50 million in gross proceeds through an equity line of credit.
IPO
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
IPO$180M+ partnership payments
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.
IPO
Laser Photonics Files Fresh S-1 for Warrant Share Resale
IPO
Laser Photonics Files Fresh S-1 for Warrant Share Resale
Laser Photonics Corp, a Nasdaq-listed industrial laser-cleaning maker, filed its third S-1 of 2026 on July 10, continuing a pattern of registering shares tied to inducement and placement-agent warrants.
IPO
Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE
IPO~$3.5M base + up to $21M contingent
Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE
Decoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.
IPO
iPower Files New S-1 as It Manages an Existing Nasdaq Listing
IPO
iPower Files New S-1 as It Manages an Existing Nasdaq Listing
iPower Inc, a Rancho Cucamonga-based consumer products company trading under "IPW," filed a new Form S-1 on July 10, its second such registration of 2026 after an earlier S-1/A in January.
IPO
Avalanche Treasury Files S-1 After Stock Crashed 73% Post-Debut
IPOGoing-concern warning
Avalanche Treasury Files S-1 After Stock Crashed 73% Post-Debut
Avalanche Treasury Corp, whose AVAT stock has fallen 73% since its Nasdaq debut via SPAC merger, filed a new S-1 as it flags crypto losses and warns it may not survive without additional financing.
IPO
Universal Safety Products Files S-1 Amid Warned Net Loss
IPO
Universal Safety Products Files S-1 Amid Warned Net Loss
Universal Safety Products filed a Form S-1 for up to 10.6 million shares on the same day it warned of a substantial sales and gross-profit decline and an expected net loss for the year ended March 31, 2026.
IPO
NeuroSpectrum Insights Amends IPO Filing a Fifth Time
IPO
NeuroSpectrum Insights Amends IPO Filing a Fifth Time
NeuroSpectrum Insights, formerly Autism Diagnostic Technologies, filed its fifth S-1/A amendment since January, the latest step in a lengthy SEC review process for its planned public offering.
IPO
Nexchip Prices $890M Hong Kong IPO at Top of Range
IPO$890 million raised
Nexchip Prices $890M Hong Kong IPO at Top of Range
Chinese chipmaker Nexchip Semiconductor priced its Hong Kong listing at HK$32.30 per share, the top of its range, raising roughly HK$6.98 billion ($890 million) as it pursues a dual Shanghai-Hong Kong listing amid a booming HK IPO market.
IPO
GridAI Technologies Amends S-1 as Energy-AI Pivot Continues
IPO
GridAI Technologies Amends S-1 as Energy-AI Pivot Continues
GridAI Technologies, formerly biopharma company Entero Therapeutics, filed an amended S-1 registering shares tied to recent PIPE financings as it repositions around energy-orchestration and grid-optimization software for AI datacenters.
IPO
Zapata Quantum's S-1/A Shows Going-Concern Risk Persists
IPO
Zapata Quantum's S-1/A Shows Going-Concern Risk Persists
Zapata Quantum filed an amended S-1/A registering 56.8 million shares for resale, disclosing ongoing losses and going-concern risk despite a recent $15 million Series D and a return to current SEC reporting status.
IPO
Mitesco Files S-1 to Register Equity Line Shares
IPOUp to $30M equity facility
Mitesco Files S-1 to Register Equity Line Shares
Nevada-incorporated Mitesco filed an S-1 to register shares issuable under a new equity line of credit, part of a small-cap financing pattern distinct from this week's AI mega-rounds.
IPO
BOA Acquisition Corp II Files for $200M Blank-Check IPO
IPO$200M target IPO
BOA Acquisition Corp II Files for $200M Blank-Check IPO
BOA Acquisition Corp II filed to raise up to $200 million in a blank-check IPO targeting real estate and infrastructure, part of a steady 2026 revival in SPAC issuance running well below the AI-mega-deal headlines.
IPO
Europe Posts Its Best VC Quarter in 4 Years as UK Leads
IPO$24B Q2 2026 European funding
Europe Posts Its Best VC Quarter in 4 Years as UK Leads
European startups raised $24 billion in Q2 2026, up two-thirds year-over-year, with UK startups alone pulling in more than $10 billion -- the region's third-largest quarter on record.
IPO
AEON Biopharma, Mobix Labs S-1 Filings Test a Thin Pipeline
IPO
AEON Biopharma, Mobix Labs S-1 Filings Test a Thin Pipeline
AEON Biopharma filed a fresh S-1 for a biosimilar program while Mobix Labs amended its filing disclosing a going-concern warning -- a reminder this week's IPO pipeline is mostly small-cap, not AI infrastructure.
IPO
Smith Micro Files Non-Dilutive S-1 for Warrant Shares
IPO
Smith Micro Files Non-Dilutive S-1 for Warrant Shares
Smith Micro Software filed a Form S-1 solely to register the resale of shares underlying previously issued warrants and convertible notes, explicitly stating the filing dilutes no existing shareholders.
IPO
This Week's Quiet IPO Calendar Is the Real Story
IPO
This Week's Quiet IPO Calendar Is the Real Story
Beyond SK Hynix's $28-29 billion Nasdaq debut, this week's US IPO calendar is nearly empty -- a sharp contrast to June's run of SpaceX, Cerebras and Lime, and a sign the pipeline is thinner than headline enthusiasm suggests.
IPO
SK Hynix Prices $28B Nasdaq Offering, 7x Oversubscribed
IPO~$28-29B raise, priced ~$158/ADS
SK Hynix Prices $28B Nasdaq Offering, 7x Oversubscribed
SK Hynix priced its Nasdaq ADS offering at roughly $158 per share on July 9 after a book that was reportedly oversubscribed 7 times, with trading set to begin July 10 under ticker SKHY.
IPO
Europe's Exit Engine Is Running on M&A, Not IPOs
IPO$7.2B M&A, Q2 2026
Europe's Exit Engine Is Running on M&A, Not IPOs
European startups exited $7.2 billion across 172 M&A deals in Q2 2026, with four of the 18 global $1 billion-plus VC-backed acquisitions coming from Europe -- while the region's IPO pipeline stays thin.
IPO
Anthropic's $50B Round Shows Why the IPO Pipeline Is Shrinking
IPO$50B Series H (May 2026)
Anthropic's $50B Round Shows Why the IPO Pipeline Is Shrinking
Anthropic's $50 billion Series H, split across a ten-investor syndicate plus separate multi-billion tranches from Google and Amazon, shows how mega private rounds are absorbing capital that once would have pushed companies toward an IPO.
IPO
The SPAC Pipeline Is Quietly Filling Back Up in 2026
IPO
The SPAC Pipeline Is Quietly Filling Back Up in 2026
A wave of small blank-check filings -- Southern Cross Acquisition II, OceanLight Acquisition and others -- is moving through the SEC this week, even as the large-cap IPO calendar stays nearly empty outside SK Hynix's Nasdaq debut.
IPO
Leef Brands Files S-1 for Public Listing
IPO
Leef Brands Files S-1 for Public Listing
Leef Brands, a Vancouver-based cannabis company, filed an S-1 registering more than 81.5 million common shares, joining a wave of smaller companies moving through the SEC pipeline this week.
IPO
Jaovi Inc Files Small S-1 From Costa Rica
IPO$120,000 total offering
Jaovi Inc Files Small S-1 From Costa Rica
Wyoming-incorporated Jaovi Inc, based in Costa Rica, filed an S-1 registering 4 million shares at $0.03 each for a total offering of just $120,000 -- illustrating the far end of the small-cap IPO pipeline.
IPO
Why 2026's IPO Window Is Actually Two Markets
IPO
Why 2026's IPO Window Is Actually Two Markets
2026's IPO market is really two separate markets: trillion-dollar AI infrastructure debuts stacked against a shakier field of traditional listings -- and only one of those two is actually working.
IPO
Standard Nuclear Sets Terms for $356M NYSE IPO
IPO$355.9M target raise
Standard Nuclear Sets Terms for $356M NYSE IPO
Standard Nuclear disclosed terms for its NYSE IPO on July 7, offering 18.25 million shares at $18-$21 to raise up to $355.9 million and fund expansion of its domestic nuclear-fuel production.
IPO
SK Hynix Launches $28B Nasdaq Bookbuilding
IPO$28.13B target raise
SK Hynix Launches $28B Nasdaq Bookbuilding
SK Hynix kicked off bookbuilding for a $28.13 billion Nasdaq ADS offering, with cornerstone investors committing up to $7 billion even as its Seoul-listed shares slid 6.7% on dilution concerns.
IPO
Nuclear Fuel Maker Standard Nuclear Files for NYSE IPO
IPOS-1 filed June 18, ticker STDN
Nuclear Fuel Maker Standard Nuclear Files for NYSE IPO
Standard Nuclear, an Oak Ridge maker of advanced TRISO reactor fuel with a $245 million backlog, filed for an NYSE IPO under ticker STDN as AI-driven power demand accelerates interest in next-generation nuclear supply chains.
IPO
Why 2026's Biggest Debuts Keep Choosing SPACs
IPO4 major 2026 SPAC routes to Nasdaq/NYSE
Why 2026's Biggest Debuts Keep Choosing SPACs
From Agility Robotics to Securitize to Elroy Air, 2026's capital-intensive hardware and infrastructure companies are increasingly choosing SPAC mergers over traditional IPOs to reach public markets faster.
IPO
Biotech's IPO Window Reopens With Record Debuts
IPO$670M-$719M record biotech raises
Biotech's IPO Window Reopens With Record Debuts
A run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.
IPO
SpaceX, Anthropic, OpenAI: Pricing the Trillion-Dollar Trio
IPO$2T, $965B, $852B -- three of the largest filings ever
SpaceX, Anthropic, OpenAI: Pricing the Trillion-Dollar Trio
SpaceX has already gone public near a $2 trillion valuation, while Anthropic and OpenAI's confidential IPO filings imply valuations of $965 billion and $852 billion, setting up 2026's biggest test of public-market AI pricing.
IPO
Europe's IPO Pipeline Fills Up After Bending Spoons
IPO$25.7B close, ~40% pop, fresh EU fund formation
Europe's IPO Pipeline Fills Up After Bending Spoons
Bending Spoons' 40% Nasdaq debut pop to a near-$26 billion valuation, alongside fresh European mega-funds like Kembara's, is reviving confidence that Europe can produce IPO-ready tech companies again.
IPO
Syntiant Discloses Losses Ahead of Nasdaq IPO
IPOIPO under ticker SYTN
Syntiant Discloses Losses Ahead of Nasdaq IPO
Edge-AI chipmaker Syntiant disclosed a $26.2 million quarterly net loss on $64.5 million in sales ahead of its Nasdaq listing under ticker SYTN, led by Citigroup, Bank of America and UBS.
IPO
Securitize Rings NYSE Bell as Tokenized Stock Era Begins
IPO$400M raised, $295M tokenized on debut
Securitize Rings NYSE Bell as Tokenized Stock Era Begins
Securitize completed its SPAC merger with Cantor Equity Partners II and rang the NYSE closing bell on July 6, becoming the first newly public company to tokenize its own stock on Solana and Avalanche on day one.
IPO
SK Hynix Files for Record $29 Billion Nasdaq IPO
IPOUp to $29.4B raise, 177.9M ADSs
SK Hynix Files for Record $29 Billion Nasdaq IPO
SK Hynix, the world's second-largest memory chipmaker and a top supplier of AI-GPU memory to Nvidia, filed to list 177.9 million ADSs on Nasdaq under ticker SKHY, seeking up to $29.4 billion in one of the largest offerings on record.
IPO
The Quiet IPO Pipeline Building Beneath the Mega-Deals
IPO10+ new S-1/S-1A filings this week
The Quiet IPO Pipeline Building Beneath the Mega-Deals
A wave of new S-1 filings this week -- spanning cybersecurity, biotech, medical devices and SPAC vehicles -- shows a broader IPO pipeline building beneath the mega-cap headlines like Agility Robotics and SK Hynix.
IPO
Intel-Backed Edge AI Chipmaker Syntiant Files for IPO
IPOS-1 filed, ticker SYTN
Intel-Backed Edge AI Chipmaker Syntiant Files for IPO
Syntiant, an Intel-backed maker of ultra-low-power AI chips for earbuds and cars with over 100 million units deployed, filed for a Nasdaq IPO under ticker SYTN after posting a $20.9 million Q1 net loss on $64.5 million revenue.
IPO
Government Cybersecurity Firm Cycurion Files for Nasdaq IPO
IPOS-1 filed, ticker CYCU
Government Cybersecurity Firm Cycurion Files for Nasdaq IPO
Cycurion, which sells AI-driven cybersecurity to the Department of Defense and Homeland Security with an $80 million backlog, filed for a Nasdaq IPO under ticker CYCU after closing a bolt-on Secuvant acquisition.
IPO
Agility's SPAC Bet: Can Real Robots Beat SPAC Volatility?
IPO$2.5B SPAC deal, largest in sector
Agility's SPAC Bet: Can Real Robots Beat SPAC Volatility?
Agility Robotics' $2.5B SPAC merger tests whether a humanoid robotics company with real warehouse revenue can avoid the boom-bust volatility that has plagued most SPAC-listed companies over the past several cycles.
IPO
Humanoid Robotics Firm Agility Goes Public via $2.5B SPAC
IPO~$2.5B valuation, $620M+ raise
Humanoid Robotics Firm Agility Goes Public via $2.5B SPAC
Agility Robotics is merging with Churchill Capital Corp XI in the largest capital raise in humanoid robotics history, with $300M+ in booked revenue but a CEO who says home robots are still a decade away.
IPO
Europe's Late-Summer IPO Pipeline Is Filling Up Fast
IPO2 European listings in one week
Europe's Late-Summer IPO Pipeline Is Filling Up Fast
Swiss healthcare REIT Infracore and German defense-communications firm Smag are both racing toward July listings, adding to a busier-than-expected European IPO calendar even as broader international indices soften.
IPO
Anthropic's IPO Math Now Implies a Trillion-Dollar Debut
IPO$1.05T-$1.15T implied valuation
Anthropic's IPO Math Now Implies a Trillion-Dollar Debut
Secondary markets are pricing Anthropic's confidential IPO filing at $1.05-$1.15 trillion, a premium over its last private round, as revenue growth accelerates ahead of an October Nasdaq target.
IPO
Why 2026's Marquee AI IPOs Keep Slipping to 2027
IPOPotential delay to 2027
Why 2026's Marquee AI IPOs Keep Slipping to 2027
OpenAI is reportedly weighing a delay of its IPO to 2027 amid volatile public markets and SpaceX's choppy post-debut trading, a hesitation that could reshape the entire 2026-2027 tech IPO pipeline.
IPO
Small-Cap Tech IPOs Are Having a Quiet Moment in 2026
IPOIPO count +7.95% YoY
Small-Cap Tech IPOs Are Having a Quiet Moment in 2026
Beyond the SpaceX and Bending Spoons headlines, 2026's tech IPO count is already running about 8% ahead of 2025, with smaller healthcare-data and industrial-tech filers like OneMedNet quietly testing the market.
IPO
IPO Market Breadth Slips as AI Jitters Spread Abroad
IPO82 IPOs priced in 2026 YTD
IPO Market Breadth Slips as AI Jitters Spread Abroad
International IPO indices softened this week even as US listings stayed active, with new SPAC filings targeting AI, quantum computing and Asia-focused deals showing the pipeline still building beneath the volatility.
IPO
SpaceX Set to Join Nasdaq-100, Unlocking ~$4.3B in Fund Buying
IPO~$7.3B combined passive inflows
SpaceX Set to Join Nasdaq-100, Unlocking ~$4.3B in Fund Buying
SpaceX will join the Nasdaq-100 before market open on July 7, just 17 days after its June IPO -- one of the fastest index inclusions on record -- forcing an estimated $4.3B in passive index-fund buying.
IPO
IQM, Europe's First Public Quantum Company, Admits the Future of the Tech Is
IPO~$1.9B valuation
IQM, Europe's First Public Quantum Company, Admits the Future of the Tech Is
IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq July 2 via a SPAC merger with RAAQ at a roughly $1.9 billion valuation, but shares traded below the IPO price for most of the day -- a lukewarm debut IQM's own prospectus.
IPO
Jersey Mike's IPO Filing Shows Just How Far AI Buzzwords Have Spread
IPOS-1 filed
Jersey Mike's IPO Filing Shows Just How Far AI Buzzwords Have Spread
Jersey Mike's Subs Inc. filed its S-1 for an IPO on July 2, mentioning 'artificial intelligence' or 'AI' 22 times despite being a sandwich-chain franchisor with no AI product offerings, TechCrunch reported the same day.
IPO
Travel App Hopper to Pay $35M in FTC Settlement Over 'Unfairly' Charging Hidden Fees
IPO$35M settlement
Travel App Hopper to Pay $35M in FTC Settlement Over 'Unfairly' Charging Hidden Fees
Hopper agreed to pay $35 million to settle FTC allegations that it used deceptive 'dark patterns' to hide fees and misrepresent the costs and benefits of its 'VIP Support' and 'Price Freeze' services, the agency announced July 2. The settlement follows a pattern of recent FTC crackdowns on hidden-fee practices at Match, StubHub, neobank Dave and Fortnite, and requires Hopper to clearly disclose all fees going forward, though the company says the practices at issue were discontinued in mid-2023, before the FTC's inquiry began.
IPO
Scribe Therapeutics, Co-Founded by Nobel Laureate Jennifer Doudna, Files S-1 for Nasdaq IPO
IPOS-1 filed
Scribe Therapeutics, Co-Founded by Nobel Laureate Jennifer Doudna, Files S-1 for Nasdaq IPO
Scribe Therapeutics filed its S-1 with the SEC on July 2, seeking to list on the Nasdaq Global Market under the ticker 'SCTX.' The clinical-stage biotech, co-founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna, has raised roughly $150 million in equity financing since 2017 and is advancing STX-1150 -- an epigenetic-silencing CRISPR candidate for cardiovascular disease -- through an Australian first-in-human trial, while disclosing only $49.7 million in cash and marketable securities against a $175.1 million accumulated deficit.
IPO
Cycurion Files S-1 as AI Cybersecurity Firm Completes Secuvant Merger
IPO~25.9M shares registered for resale
Cycurion Files S-1 as AI Cybersecurity Firm Completes Secuvant Merger
Cycurion, a McLean, Virginia-based AI-driven IT cybersecurity and public-sector technology firm, filed a Form S-1 covering nearly 26 million shares for resale, following its completed merger with security services firm Secuvant, which closed June 3, 2026.
IPO
Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1
IPOUp to $25M equity line
Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1
Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.
IPO
Bending Spoons' Rocky First Week: 40% Pop, Then an 8.5% Slide
IPO$1.68B raised / ~$25B cap
Bending Spoons' Rocky First Week: 40% Pop, Then an 8.5% Slide
Bending Spoons surged 40% on its Nasdaq debut in the largest software IPO of 2026, then gave back 8.5% the next trading day, underscoring how volatile even a successful AI-era IPO's first week can be.
IPO
IPOs and M&A Soared to a Record $113B in Q2 2026 as the AI Boom Reshapes Exits
IPO$113B in $1B+ M&A (record quarter)
IPOs and M&A Soared to a Record $113B in Q2 2026 as the AI Boom Reshapes Exits
Crunchbase News reported July 2 that 32 companies went public above a $1 billion valuation in Q2 2026 and 24 more were acquired at $1 billion-plus valuations totaling a record $113 billion, headlined by SpaceX's $1.77 trillion IPO (raising $75 billion) and.
IPO
Scribe Therapeutics Files for $75M IPO to Test Early-Stage Biotech Appetite
IPOUp to $75M IPO
Scribe Therapeutics Files for $75M IPO to Test Early-Stage Biotech Appetite
Scribe Therapeutics filed to raise up to $75 million in a Nasdaq IPO, becoming an early test of public-market appetite for Phase 1 biotechs -- its lead candidate, a CRISPR-based epigenetic therapy targeting PCSK9 to lower LDL cholesterol, is already in a.
IPO
Uber-Backed Lime Prices IPO at $25, Pops on Nasdaq Debut After Years of Delay
IPO$174M IPO, +9% debut
Uber-Backed Lime Prices IPO at $25, Pops on Nasdaq Debut After Years of Delay
Lime, the Uber-backed scooter and e-bike rental company, priced its Nasdaq IPO at $25 per share on June 30 — the midpoint of its $24-$26 range — selling 6.96 million shares to raise $174 million at a $1.6 billion valuation. Shares jumped about 9% in their first hour of trading July 1 under ticker LIME, capping years of on-again, off-again public-listing speculation for the micromobility company.
IPO
Bending Spoons Defies the SaaS Slump, Surges 40% on IPO Day to a $25.7B
IPO$25.7B market cap (+40% day one)
Bending Spoons Defies the SaaS Slump, Surges 40% on IPO Day to a $25.7B
Milan-based Bending Spoons priced its IPO at $29 per share, raised $1.68 billion, and closed its first trading day up 40% at $40.50, pushing its market cap to $25.7 billion -- more than double its prior $11 billion private valuation -- TechCrunch reported.
IPO
Bending Spoons Defies the SaaS Slump, Surges 40% on Nasdaq Debut to a Near-$26B Close
IPO$1.68B raised, +40% debut
Bending Spoons Defies the SaaS Slump, Surges 40% on Nasdaq Debut to a Near-$26B Close
Bending Spoons priced its Nasdaq IPO at $29 per share on June 30 — above its $26-$28 marketed range — raising $1.68 billion at an $18.4 billion valuation, then closed its first trading day up roughly 40% near $25.7 billion. The Milan-based company, which buys and revitalizes aging tech brands including AOL, Evernote, Meetup and Vimeo, posted $601 million in Q1 revenue and swung to a $27.4 million profit from a $112 million loss a year earlier.
IPO
VenHub Global Files Amended S-1 for Nasdaq Direct Listing of Fully Autonomous Robotic Stores
IPODirect listing, no new capital
VenHub Global Files Amended S-1 for Nasdaq Direct Listing of Fully Autonomous Robotic Stores
VenHub Global filed an S-1/A amendment on July 1 as it works toward a direct listing on Nasdaq under ticker VNHB, registering up to 15.5 million shares for sale by existing holders rather than raising new capital. The company builds fully autonomous, AI-driven robotic smart stores, has deployed three to date, and carries an accumulated deficit near $98.8 million with auditors flagging substantial going-concern doubt.
IPO
Bending Spoons Surges 40% on Nasdaq Debut After $18.4B IPO Priced Above Range
IPO$1.68B IPO, shares +40%
Bending Spoons Surges 40% on Nasdaq Debut After $18.4B IPO Priced Above Range
Milan-based Bending Spoons priced its Nasdaq IPO at $29 a share on June 30 — above its marketed $26-$28 range — raising $1.68 billion and valuing the company at roughly $18.4 billion. Shares opened at $31 on July 1, touched an intraday high of $42.50, and closed the session at $40.50, up nearly 40%, making it one of the strongest software IPO debuts of 2026 despite a broader SaaS slowdown.
IPO
Micromobility Leader Lime Debuts on Nasdaq
IPO$24-$26/share, ~$167M-$181M raise
Micromobility Leader Lime Debuts on Nasdaq
Shared e-bike and scooter operator Lime listed on Nasdaq on July 1, pricing nearly 7 million shares between $24 and $26, becoming one of the first profitable consumer mobility names to test public markets in 2026.
IPO
OneMedNet Files S-1 to Register Shares Under $8.5M Standby Equity Purchase Agreement
IPOUp to 11.68M shares
OneMedNet Files S-1 to Register Shares Under $8.5M Standby Equity Purchase Agreement
OneMedNet Corporation, a Minnesota-based healthcare data company, filed a Form S-1 on July 1 registering up to 11.68 million shares of common stock, including up to 8.5 million shares issuable under a Standby Equity Purchase Agreement (SEPA) dated the same day. SEPAs let a public company draw down capital incrementally by selling shares to an investor at its own discretion, a financing structure often used by smaller-cap companies that need flexible access to capital without a traditional follow-on offering.
IPO
Actelis Networks Files Fresh S-1 as Hybrid Fiber-Copper Networking Firm Deepens Its Public Listing
IPOS-1 filed
Actelis Networks Files Fresh S-1 as Hybrid Fiber-Copper Networking Firm Deepens Its Public Listing
Actelis Networks filed a new Form S-1 with the SEC on July 1, following an earlier registration statement that went effective in November 2025. The Sunnyvale, California-based company sells hybrid fiber-copper-coax networking equipment for IoT, security and telecom deployments, letting customers deploy fast, secure connectivity over existing copper and coaxial infrastructure without a full fiber rebuild.
IPO
Asia AI Group Files Fresh S-1, Widening the AI-Branded IPO Pipeline Beyond the Frontier Labs
IPOS-1 filed
Asia AI Group Files Fresh S-1, Widening the AI-Branded IPO Pipeline Beyond the Frontier Labs
Asia AI Group Inc filed a Form S-1 with the SEC on July 1, joining a wave of smaller companies filing AI-branded registration statements even as OpenAI, Anthropic and SpaceX dominate IPO headlines with valuations near or above $1 trillion. The filing adds to a growing list of small-cap AI-named S-1s this year, underscoring how far the AI-IPO enthusiasm has spread beyond the handful of marquee frontier labs getting most investor attention.
IPO
Freedom Metals Acquisition Corp Amends S-1 for Critical-Metals-Focused SPAC IPO
IPOSPAC IPO filing
Freedom Metals Acquisition Corp Amends S-1 for Critical-Metals-Focused SPAC IPO
Freedom Metals Acquisition Corp filed an S-1/A amendment on July 1, detailing a blank-check company structure targeting acquisitions in the critical metals and mining sector. Sponsor NLC America SPAC 1 LLC and underwriter Cohen & Company Capital Markets have committed to purchase private placement units worth up to roughly $9.1 million if the over-allotment option is exercised in full, positioning the SPAC to hunt for a target in a sector newly critical to both AI data-center buildouts and defense supply chains.
IPO
Lime Rings the Nasdaq Bell at $25 as Uber-Backed Scooter Giant Reaches $1.8B Market Cap
IPO$174M IPO at $1.8B
Lime Rings the Nasdaq Bell at $25 as Uber-Backed Scooter Giant Reaches $1.8B Market Cap
Lime — the world's largest shared micromobility operator, formally Neutron Holdings — priced its Nasdaq IPO at the $25 midpoint on June 30 and begins trading July 1 under ticker LIME, raising roughly $174-182M at a $1.63-1.8B market cap. Uber, which owns a meaningful stake and operates Lime bikes and scooters through its ride-hail app, is a key backer testing whether the scooter category still has a public-market future after Bird's bankruptcy.
IPO
QumulusAI Files S-1/A for Nasdaq Direct Listing as GPU-Cloud Provider to Underserved AI Customers
IPODirect listing filed
QumulusAI Files S-1/A for Nasdaq Direct Listing as GPU-Cloud Provider to Underserved AI Customers
QumulusAI filed a seventh S-1/A amendment on July 1 ahead of a planned Nasdaq direct listing, detailing an Atlanta-based GPU-as-a-service business built from the 2022 merger of a blockchain-hosting company and a data-center asset firm, later rebranded after acquiring The Cloud Minders in 2025. The company reported $3.4 million in quarterly revenue against a $5.5 million operating loss, is scaling toward 120 megawatts and up to 90,000 Nvidia B200/B300 GPUs, and disclosed going-concern risk in its filing.
IPO
Encore Medical Files Amended S-1 to Fund US Trials for Its Heart-Defect Closure Device
IPO~$12.6M-$14.67M
Encore Medical Files Amended S-1 to Fund US Trials for Its Heart-Defect Closure Device
Encore Medical filed an amended S-1 on July 1 ahead of a planned NYSE American listing under ticker EMI, offering 3 million shares at an expected $5.00 each to raise roughly $12.6-14.67 million to fund US clinical trials for its catheter-delivered heart-defect closure device, which has completed more than 35,000 implants outside the United States but has not yet been approved for US sale. Underwriters BofA Securities, Goldman Sachs and Morgan Stanley are jointly leading the offering.
IPO
Already-Public Actelis Networks Files New S-1 to Amend Its Equity Line With White Lion Capital
IPOUp to 15.85M shares
Already-Public Actelis Networks Files New S-1 to Amend Its Equity Line With White Lion Capital
Actelis Networks, the Nasdaq-listed hybrid fiber-coax networking company, filed a Form S-1 on July 1 to re-register shares tied to an amended equity line of credit (ELOC) with White Lion Capital, after 10 million of the 10.6 million shares originally registered for the arrangement in October 2025 remained unsold. The amendment registers up to 15.85 million shares across revised ELOC shares, commitment shares and warrant shares — a dilutive financing structure for a cybersecurity-hardened networking equipment maker, rather than a new IPO.
IPO
Solid-State Battery Maker Factorial Energy Lists on Nasdaq at $1.3B via SPAC Merger
IPO$1.3B equity value
Solid-State Battery Maker Factorial Energy Lists on Nasdaq at $1.3B via SPAC Merger
Factorial Energy completed its business combination with Cartesian Growth Corporation III and began trading on Nasdaq under ticker FAC on June 8, implying about $1.3 billion in equity value and delivering over $100 million in gross proceeds to fund commercialization of its solid-state batteries for defense, data centers, drones, robotics and e-mobility. Stellantis holds a 9.5% stake in the combined company, underscoring continued automaker conviction in solid-state battery technology.
IPO
Encore Medical Prices Structural Heart IPO at $5/Share on NYSE American as Cash Runway Tightens
IPO$5.00/share IPO
Encore Medical Prices Structural Heart IPO at $5/Share on NYSE American as Cash Runway Tightens
Encore Medical, a structural heart device company developing transcatheter septal occlusion products, filed its latest S-1/A on June 30, targeting an IPO of 3 million shares at an expected $5 per share on NYSE American under ticker EMI. The company's cash balance stood at just $34,619 as of March 31, 2026, underscoring how urgently it needs the offering to fund ongoing US clinical trials.
IPO
SeeQC Files S-1 for Nasdaq IPO to Fund Digital Quantum Computing Chips
IPO~$1B valuation
SeeQC Files S-1 for Nasdaq IPO to Fund Digital Quantum Computing Chips
SeeQC, which builds digital quantum-computing infrastructure, filed a Form S-1 to list on the Nasdaq Global Market under ticker 'SEQC,' paired with a $65 million PIPE financing that values the combined entity at roughly $1 billion. The company integrates superconducting single-flux-quantum logic with cryogenic CMOS to shrink the wiring and heat load of quantum systems -- reporting $4.2 million in 2025 revenue against a $12.2 million net loss.
IPO
SunPower Files S-1 as Reborn Residential Solar Company Eyes Public Markets
IPOS-1 filed
SunPower Files S-1 as Reborn Residential Solar Company Eyes Public Markets
SunPower filed a Form S-1 with the SEC on June 29, registering shares for resale as the rebuilt residential and small-business solar company steps toward the public markets. Trading under ticker SPWR, the company is pitching an end-to-end offering -- technology platform, financing and high-performance equipment -- in a U.S. solar market reshaped by shifting incentives and consolidation.
IPO
SeeQC Files S-1 as Quantum Computing IPO Wave Widens Beyond IonQ and D-Wave
IPOS-1 filed
SeeQC Files S-1 as Quantum Computing IPO Wave Widens Beyond IonQ and D-Wave
Digital quantum computing firm SeeQC filed an S-1 on June 29, becoming one of the first pure-play quantum specialists to file since the 2021 SPAC rush. SeeQC's superconducting chips integrate quantum bits directly with classical control electronics, targeting scalable systems that competitors say require room-scale cabinets today.
IPO
Spine-Surgery Device Maker Tenon Medical Files to Raise Fresh Capital
IPOS-1MEF filed
Spine-Surgery Device Maker Tenon Medical Files to Raise Fresh Capital
Tenon Medical filed an S-1MEF with the SEC on June 29, registering additional shares to support a public offering as the small-cap medical-device company funds the commercialization of its sacroiliac (SI) joint fusion system. The filing is a window into the steady, less-glamorous flow of medtech issuers tapping public markets even as AI and mega-IPOs dominate headlines.
IPO
Q2 2026 Delivers the Most Billion-Dollar Startup Exits Since the 2021 Peak
IPOMost $1B+ exits since 2021
Q2 2026 Delivers the Most Billion-Dollar Startup Exits Since the 2021 Peak
Startup exits worth $1 billion or more were more numerous in Q2 2026 than at any point since the 2021 market peak, according to Crunchbase data -- powered by SpaceX's record IPO (a $2.1 trillion first-day market cap on $75 billion raised), Cerebras's and Quantinuum's debuts, and SpaceX's $60 billion acquisition of Cursor. The quarter signals the long-frozen exit window has decisively reopened for late-stage tech.
IPO
Drone-Delivery Pioneer Matternet Files an S-1 to Register Shares After Going Public
IPOS-1 filed
Drone-Delivery Pioneer Matternet Files an S-1 to Register Shares After Going Public
Matternet, which bills itself as the world's only FAA type-certified drone-delivery platform, filed a Form S-1 with the SEC, following its May 2026 reverse-merger debut and a ~$33 million private placement. The filing registers shares as the company funds the rollout of its next-generation delivery platform across food, retail and healthcare -- a marker of how the autonomy IPO pipeline is broadening beyond ground robotaxis.
IPO
Crunchbase: Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since the 2021 Peak
IPOMost exits since 2021
Crunchbase: Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since the 2021 Peak
Crunchbase data published June 29 shows venture-backed startup exits valued at $1 billion or more hit their highest count in Q2 2026 since the 2021 market peak, headlined by SpaceX's roughly $2.1 trillion first-day market cap IPO and SpaceX's subsequent $60 billion all-stock acquisition of Cursor — the priciest purchase of a private, venture-backed startup ever, nearly double Google's $32 billion Wiz deal.
IPO
Consumer Brand House AMASS Brands Files S-1, Testing the CPG IPO Window
IPOS-1 filed
Consumer Brand House AMASS Brands Files S-1, Testing the CPG IPO Window
AMASS Brands filed a Form S-1 with the SEC on June 29, stepping toward a public listing as a consumer-brands company -- a notable test of whether the reopened IPO window extends beyond AI and deep tech into consumer packaged goods. The filing adds a different flavor to a 2026 pipeline dominated by frontier-tech and infrastructure names.
IPO
Autonomous Industrial Drone Firm Exyn Technologies Files S-1 Amid Defense-Tech IPO Rush
IPOS-1 filed
Autonomous Industrial Drone Firm Exyn Technologies Files S-1 Amid Defense-Tech IPO Rush
Exyn Technologies filed an S-1 on June 29 to go public, joining a wave of autonomy and defense-tech companies pursuing 2026 IPOs. Its GPS-denied drone autonomy stack ships into mining, industrial inspection and defense customers — a category directly benefiting from Pentagon's Iran-war-accelerated drone procurement push.
IPO
Autonomous-Drone Maker Exyn Technologies Files S-1 as Physical AI Heads to Market
IPOS-1 filed
Autonomous-Drone Maker Exyn Technologies Files S-1 as Physical AI Heads to Market
Exyn Technologies, which builds fully autonomous aerial robots for GPS-denied environments like underground mines, filed a Form S-1 with the SEC. The company's drones have achieved Level 4 autonomy -- the highest aerial autonomy demonstrated to date, with onboard mapping and no human pilot -- positioning Exyn in the fast-emerging 'physical AI' category just as governments and investors pour capital into embodied robotics.
IPO
Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since 2021
IPOMost exits since 2021
Q2 2026 Delivered the Most Billion-Dollar Startup Exits Since 2021
Q2 2026 produced the most billion-dollar startup exits since the 2021 boom, led by SpaceX's blockbuster IPO and its record $60 billion purchase of Cursor parent Anysphere, according to Crunchbase data. While exit counts still trail the 2021 peak, the sheer size of deals -- with Anthropic and OpenAI now filing to test the trillion-dollar mark -- is the defining feature of the reopened liquidity window.
IPO
Classover Rebrands as KIDZ AI and Files S-1 to Fund AI Learning and Compute Push
IPOS-1 filed
Classover Rebrands as KIDZ AI and Files S-1 to Fund AI Learning and Compute Push
KIDZ AI Inc. (Nasdaq: KIDZ), the AI-education company formerly known as Classover Holdings, filed a Form S-1 with the SEC as it pivots from live online enrichment classes for kids toward AI-powered learning systems -- and, notably, AI compute infrastructure and GPU cloud. The rebrand-and-refile captures both the edtech-AI wave and the 2026 trend of small caps chasing the AI-infrastructure story.
IPO
Ionic Digital Files S-1 for Nasdaq Listing as Bitcoin-Mining IPOs Return with a Vengeance
IPOS-1 filed
Ionic Digital Files S-1 for Nasdaq Listing as Bitcoin-Mining IPOs Return with a Vengeance
Ionic Digital filed a Form S-1 on June 26 to list on Nasdaq, joining a fresh wave of bitcoin-mining IPOs riding a record-high BTC price and post-halving miner economics. The company operates data-center-scale hosted mining infrastructure and is pivoting portions of capacity toward AI compute contracts.
IPO
TEN Holdings Prices a $7.5M Offering via S-1MEF as Micro-Cap Issuance Stirs
IPO$7.5M offering
TEN Holdings Prices a $7.5M Offering via S-1MEF as Micro-Cap Issuance Stirs
TEN Holdings (Nasdaq: XHLD), the parent of event production and broadcasting firm Ten Events, filed an S-1MEF with the SEC and priced a $7.5 million offering of 7.5 million shares at $1.00 each, with WestPark Capital as sole placement agent. The deal is a small but telling sign that capital-markets activity is reaching well down the cap-size spectrum, not just the marquee AI and biotech names.
IPO
Jupiter Neurosciences Files S-1 to Fund Its Neuroinflammation and Longevity Pipeline
IPOS-1 filed
Jupiter Neurosciences Files S-1 to Fund Its Neuroinflammation and Longevity Pipeline
Clinical-stage biotech Jupiter Neurosciences (Nasdaq: JUNS) filed a Form S-1 with the SEC to register fresh capital as it advances its lead candidate JOTROL, a proprietary resveratrol platform targeting rare and neuroinflammatory CNS disorders and, increasingly, longevity. The filing adds another central-nervous-system name to a 2026 biotech pipeline that keeps widening alongside AI and chips.
IPO
QumulusAI Amends S-1 Again as GPU-Cloud Provider for Underserved Mid-Market AI Teams Nears Nasdaq Debut
IPOS-1/A filed
QumulusAI Amends S-1 Again as GPU-Cloud Provider for Underserved Mid-Market AI Teams Nears Nasdaq Debut
QumulusAI filed its latest S-1/A amendment with the SEC on June 26, continuing a string of amendments dating back to February as it works toward a Nasdaq listing. The company delivers rapid-deployment, GPU-powered cloud infrastructure targeted at small and mid-market AI teams — machine learning groups, AI infrastructure startups and research institutions — that large hyperscalers often underserve or price out.
IPO
Akari Therapeutics Files an S-1/A to Fund Its TROP2 Cancer Drug Toward the Clinic
IPOS-1/A filed
Akari Therapeutics Files an S-1/A to Fund Its TROP2 Cancer Drug Toward the Clinic
Oncology biotech Akari Therapeutics (Nasdaq: AKTX) filed a Form S-1/A with the SEC to register capital as it advances AKTX-101, a TROP2-targeting antibody-drug conjugate built on its proprietary PH1 payload platform. The filing adds another clinical-stage cancer name to a 2026 capital-markets pipeline that biotech is increasingly populating alongside AI and chips.
IPO
SpaceX's $60B Cursor Deal Puts the US on Track for a Record Startup M&A Year
IPO$119.8B+ YTD
SpaceX's $60B Cursor Deal Puts the US on Track for a Record Startup M&A Year
Acquirers have spent at least $119.8 billion buying US startups so far in 2026, on pace to beat 2025's record, with SpaceX's $60 billion purchase of Cursor parent Anysphere -- the largest startup acquisition ever -- leading the charge. Biotech made up half the top-10 deals, signaling that the exit window has reopened broadly, not just for AI.
IPO
GPS-Monitoring Tech Firm Track Group Files a Form S-1 With the SEC
IPOS-1 filed
GPS-Monitoring Tech Firm Track Group Files a Form S-1 With the SEC
Track Group, which designs location-tracking devices and the software and analytics behind them, filed a Form S-1 with the SEC. The filing adds a govtech and public-safety hardware name to a 2026 IPO pipeline dominated by AI labs and semiconductors -- a reminder that the listing window is broadening to less glamorous, cash-generating niches.
IPO
Energy-Midstream Operator Vivakor Files an Amended S-1 Amid Crude Volatility
IPOS-1/A filed
Energy-Midstream Operator Vivakor Files an Amended S-1 Amid Crude Volatility
Vivakor, a Nasdaq-listed integrated energy transportation, storage and crude-logistics operator, filed an amended Form S-1 with the SEC. The filing -- coming as crude-oil volatility lifts demand for midstream infrastructure -- highlights how the IPO and registration pipeline extends well beyond tech into the physical energy economy underpinning the AI buildout.
IPO
Biospecimen Marketplace iSpecimen Files a Form S-1 With the SEC
IPOS-1 filed
Biospecimen Marketplace iSpecimen Files a Form S-1 With the SEC
iSpecimen, which operates an online marketplace connecting medical researchers with human biological specimens, filed a Form S-1 with the SEC. The filing adds a health-data and life-sciences infrastructure name to a 2026 IPO pipeline that has skewed heavily toward AI labs and semiconductors.
IPO
Cancer-Immunotherapy Developer Liminatus Pharma Files S-1 to Go Public
IPOS-1 filed
Cancer-Immunotherapy Developer Liminatus Pharma Files S-1 to Go Public
Liminatus Pharma, a clinical-stage biotech developing cancer immunotherapies, filed a Form S-1 with the SEC for an IPO. The filing is a sign of life in the long-dormant biotech IPO market, which has lagged the tech-led reopening.
IPO
SaaS-Security Startup Spin AI Files S-1 for an IPO
IPOS-1 filed
SaaS-Security Startup Spin AI Files S-1 for an IPO
Spin AI, which builds AI-driven security and data-protection software for SaaS applications, filed a Form S-1 with the SEC to go public. The filing adds an enterprise-security name to a widening IPO pipeline, riding demand for tools that protect the sprawling stack of cloud apps companies now run.
IPO
Low-Power Chipmaker Ambiq Micro Files S-1MEF, Racing Toward an Imminent IPO Pricing
IPOIPO imminent
Low-Power Chipmaker Ambiq Micro Files S-1MEF, Racing Toward an Imminent IPO Pricing
Ambiq Micro, the ultra-low-power semiconductor company whose chips power wearables and edge-AI devices, filed an S-1MEF with the SEC -- a registration that companies submit immediately before an IPO prices. The filing signals Ambiq is in the final stretch toward going public as appetite for chip and edge-AI names returns.
IPO
Subsea Robotics Firm Nauticus Robotics Files S-1/A Amid Defense-Autonomy Demand
IPOS-1/A filed
Subsea Robotics Firm Nauticus Robotics Files S-1/A Amid Defense-Autonomy Demand
Nauticus Robotics, which builds autonomous subsea robots and the AI software that runs them, filed an amended S-1 (S-1/A) with the SEC. The filing rides a wave of investor appetite for autonomous maritime and defense systems, the same demand fueling private giants like Saronic.
IPO
Ambiq Micro Files S-1 to List on NYSE, Betting Ultra-Low-Power AI Silicon on Public Investors
IPOS-1 filed
Ambiq Micro Files S-1 to List on NYSE, Betting Ultra-Low-Power AI Silicon on Public Investors
Austin-based Ambiq Micro filed an S-1 on June 22 to list on the NYSE, marking the largest ultra-low-power AI chip IPO filing of 2026. Ambiq's Apollo family powers ~200 million shipped smartwatches, wearables and IoT sensors and is a leading candidate to define on-device AI silicon in consumer electronics.
IPO
Autonomous Smart-Store Maker VenHub Global Files S-1 for an IPO
IPOS-1 filed
Autonomous Smart-Store Maker VenHub Global Files S-1 for an IPO
VenHub Global, which builds fully autonomous, AI-powered smart stores, filed a Form S-1 with the SEC to go public. The filing brings a physical-AI retail automation play to the IPO pipeline, betting that robotic, self-operating storefronts can reshape convenience retail.
IPO
Edge-AI Chipmaker Ambiq Micro Files S-1 for a Nasdaq IPO
IPOS-1 filed
Edge-AI Chipmaker Ambiq Micro Files S-1 for a Nasdaq IPO
Austin-based Ambiq Micro filed its S-1 to go public, pitching investors on ultra-low-power semiconductors for AI at the edge. Its proprietary SPOT technology claims to run chips at roughly a tenth of normal voltage for up to 80% energy savings -- a timely story as AI's power appetite dominates the narrative.
IPO
Uber-Backed Lime Files to IPO on Nasdaq as 'LIME' After $886M Revenue Year
IPO~$200M target
Uber-Backed Lime Files to IPO on Nasdaq as 'LIME' After $886M Revenue Year
Neutron Holdings, the parent of micromobility operator Lime, has filed to go public on the Nasdaq under the ticker 'LIME,' targeting roughly $200 million in proceeds at about a $1.8 billion valuation. Lime crossed $886 million in revenue in 2025 with positive free cash flow, but warned of 'substantial doubt' about continuing as a going concern without the raise.
IPO
Japan's Go Surges 21% in the Country's Biggest 2026 IPO, Then Races Toward Robotaxis
IPO¥88.6B IPO
Japan's Go Surges 21% in the Country's Biggest 2026 IPO, Then Races Toward Robotaxis
Go, Japan's dominant ride-hailing app, jumped 21% in its Tokyo debut after a 25x-oversubscribed ¥88.6 billion offering -- the country's largest IPO of 2026 -- and is now steering the proceeds toward Waymo-powered robotaxis and acquisitions. It's a rare profitable, category-leading tech listing, and a signal that the IPO thaw has gone global.
IPO
Japan's Top Taxi App Go Raises $580M in Tokyo's Biggest IPO of 2026, Betting the Proceeds on Robotaxis
IPO~$580M
Japan's Top Taxi App Go Raises $580M in Tokyo's Biggest IPO of 2026, Betting the Proceeds on Robotaxis
Go Inc., Japan's dominant ride-hailing app, raised about $580 million in the country's largest IPO of the year and jumped as much as 21% on its Tokyo debut. The Goldman-backed offering was 25x oversubscribed, and Go is funneling the proceeds into robotaxis -- a Waymo partnership aimed at Japan's worsening driver shortage.
IPO
Chipmaker Mobix Labs Files S-1 as Semiconductor Names Test the IPO Window
IPOS-1 filed
Chipmaker Mobix Labs Files S-1 as Semiconductor Names Test the IPO Window
Mobix Labs filed an S-1 registration statement with the SEC, adding a semiconductor name to a 2026 IPO pipeline increasingly stocked with companies tied to the AI and connectivity buildout. The filing is an early step that signals confidence chip-sector stories can find public-market demand in the current window.
IPO
Bleichroeder Acquisition Corp. III Files S-1 as Blank-Check IPOs Quietly Return
IPOS-1 filed
Bleichroeder Acquisition Corp. III Files S-1 as Blank-Check IPOs Quietly Return
Bleichroeder Acquisition Corp. III filed an S-1 with the SEC for a new blank-check IPO, the latest in a string of SPAC filings testing whether the structure can return on disciplined terms. After the 2021 boom-and-bust, sponsors are betting a healthier IPO tape gives blank-check vehicles a second life.
IPO
Standard Nuclear Files S-1, Taking Advanced Nuclear to Public Markets
IPOS-1 filed
Standard Nuclear Files S-1, Taking Advanced Nuclear to Public Markets
Standard Nuclear filed an S-1 registration statement with the SEC, moving to tap public markets as demand for advanced nuclear fuel and small modular reactors surges alongside the AI data-center power crunch. The filing adds a clean-energy name to a pipeline that has been dominated by AI and space.
IPO
Morgan Stanley Files Amended S-1s for Solana and Ethereum Trusts, Widening the Crypto-ETF Door
IPOS-1/A filed
Morgan Stanley Files Amended S-1s for Solana and Ethereum Trusts, Widening the Crypto-ETF Door
Morgan Stanley filed amended S-1 registration statements for both a Solana Trust and an Ethereum Trust with the SEC, pushing a blue-chip Wall Street name deeper into spot-crypto products beyond Bitcoin. The filings signal that institutional crypto access is broadening from BTC into the next tier of large-cap tokens.
IPO
Standard Nuclear Files S-1, Putting Advanced Nuclear Fuel on the IPO Runway
IPOS-1 filed
Standard Nuclear Files S-1, Putting Advanced Nuclear Fuel on the IPO Runway
Standard Nuclear filed an S-1 registration statement with the SEC, pushing a domestic advanced-nuclear-fuel company toward public markets. The filing rides the same AI-power demand wave fueling fusion, and signals that the IPO pipeline is broadening from software into hard-tech energy.
IPO
AIM ImmunoTech Files S-1 as Biotech Joins the Reopening IPO Pipeline
IPOS-1 filed
AIM ImmunoTech Files S-1 as Biotech Joins the Reopening IPO Pipeline
AIM ImmunoTech filed an S-1 with the SEC, adding a clinical-stage biotech name to a public-market pipeline that has been widening past tech into energy and life sciences. Biotech listings have been among the slowest to thaw, so fresh filings are a useful read on whether risk appetite is returning to the sector.
IPO
Morgan Stanley Files for an Ethereum Trust as Wall Street Deepens Its Crypto Push
IPOS-1/A filed
Morgan Stanley Files for an Ethereum Trust as Wall Street Deepens Its Crypto Push
Morgan Stanley filed an amended S-1 for an Ethereum Trust, a single-asset vehicle giving investors regulated exposure to ETH, alongside a parallel Solana Trust filing. The move signals a bulge-bracket bank broadening institutional crypto access beyond Bitcoin into the next tier of digital assets.
IPO
SpaceX (SPCX) -- Record $85.7B IPO, Up 58% in Four Sessions
IPO$85.7B
SpaceX (SPCX) -- Record $85.7B IPO, Up 58% in Four Sessions
Priced at $135, opened at $161, and now up roughly 58% over its first four trading sessions, with a market cap that has overtaken Tesla's. Days after listing, SpaceX is already deploying its new currency on a $60B all-stock bid for Cursor.
IPO
EigenQ Goes Public via $3B SPAC -- Quantum Cybersecurity Hits Wall Street
IPO$3B valuation
EigenQ Goes Public via $3B SPAC -- Quantum Cybersecurity Hits Wall Street
Quantum-cybersecurity firm EigenQ is going public through a SPAC merger with Silicon Valley Acquisition Corp at a $3B valuation, raising about $215M. The company cites a $1.1B backlog and 25% revenue growth in 2025 -- a rare deep-tech listing that isn't a pure AI play.
IPO
Japan's GO Ride-Hail Prices IPO, Closes 10% Above Offering to Fund Robotaxis
IPO+10% day 1
Japan's GO Ride-Hail Prices IPO, Closes 10% Above Offering to Fund Robotaxis
Japanese ride-hailing app GO went public and closed about 10% above its offering price, directing proceeds toward robotaxi development and autonomous-driving partnerships. The debut is a fresh sign the IPO thaw is reaching beyond U.S. mega-caps to international tech with concrete AI roadmaps.
IPO
Kardigan Files S-1MEF, Clearing the Last Step Toward Its Biotech IPO
IPOS-1MEF filed
Kardigan Files S-1MEF, Clearing the Last Step Toward Its Biotech IPO
Cardiovascular biotech Kardigan filed an S-1MEF with the SEC -- a short-form registration used to register additional shares immediately before an offering goes effective. The filing signals Kardigan's IPO is imminent, a sign the biotech listing window is creaking back open alongside tech.
IPO
Klarna Prices $1.2B IPO at $25B -- BNPL Returns to Public Markets
IPO$25B valuation
Klarna Prices $1.2B IPO at $25B -- BNPL Returns to Public Markets
Klarna priced its IPO at a $25B valuation, raising $1.2B and reopening the consumer-fintech window that's been shut since 2022. The buy-now-pay-later pioneer is profitable again after a brutal repricing -- and its debut is the real test of whether public markets will pay up for fintech in an AI-dominated tape.
IPO
bioAffinity Files S-1 as Lung Cancer Test Sales Triple
IPO
bioAffinity Files S-1 as Lung Cancer Test Sales Triple
bioAffinity Technologies filed an S-1 as its noninvasive CyPath Lung cancer test, which shows 92% sensitivity in clinical trials, posted nearly 300% year-over-year unit sales growth in April 2026.
IPO
SpaceX IPO Shatters Records: $85.7B Raised, Valuation Crosses $2 Trillion
IPO$85.7B
SpaceX IPO Shatters Records: $85.7B Raised, Valuation Crosses $2 Trillion
SpaceX raised $85.7B across 639M shares in the largest IPO in history, tripling Saudi Aramco's 2019 record. Priced at $135, it opened at $161 and now trades at $178 -- a 32% gain on the offer price that minted billions in day-one paper gains for early employees and secondary-market buyers.
IPO
OpenAI and Anthropic File Confidential S-1s -- IPOs Expected 2026
IPO
OpenAI and Anthropic File Confidential S-1s -- IPOs Expected 2026
The two most valuable private AI companies -- OpenAI at ~$852B, Anthropic at ~$965B -- have both filed confidentially with the SEC. When they list, all six MANGOS companies will be public.
IPO
Research Alliance Files for Its Fourth Healthcare SPAC
IPO
Research Alliance Files for Its Fourth Healthcare SPAC
Research Alliance Corp IV filed for a $75 million IPO of 7.5 million Class A shares, the fourth blank-check company from a sponsor group that has repeatedly targeted healthcare-sector reverse mergers.
IPO
Matternet Becomes First Pure-Play Drone Delivery Company to Go Public
IPO$33M raised
Matternet Becomes First Pure-Play Drone Delivery Company to Go Public
Matternet, the FAA type-certified drone delivery platform, completed a reverse merger to go public and raised $33 million in a private placement alongside the transaction, closing May 22 and making it the first publicly reporting company focused exclusively on drone delivery. CEO Andreas Raptopoulos framed 2026 as the inflection point for U.S. drone delivery as the company expands across healthcare, retail and restaurant delivery.
IPO
HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise
IPO
HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise
HCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.
IPO
Cerebras (CBRS) Continues Hot Streak -- Up 68% Since May IPO
IPO$3.5B raise
Cerebras (CBRS) Continues Hot Streak -- Up 68% Since May IPO
Cerebras is the market's clearest bet on AI hardware scarcity -- up 68% since its May debut at $312. The AI chipmaker trades at a premium pricing in years of Nvidia-alternative demand.